Both	O
Stat3	B-protein
-activation	O
and	O
Stat3	B-protein
-independent	O
BCL2	B-protein
downregulation	O
are	O
important	O
for	O
interleukin-6	B-protein
-induced	O
apoptosis	O
of	O
1A9-M	B-cell_line
cells	I-cell_line
.	O

A	O
unique	O
subclone	O
of	O
a	O
bone	B-cell_line
marrow-derived	I-cell_line
stromal	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
BMS2.4	B-cell_line
,	O
produces	O
soluble	B-protein
factors	I-protein
that	O
inhibit	O
proliferation	O
of	O
several	O
types	O
of	O
hematopoietic	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

An	O
understanding	O
of	O
these	O
molecules	O
may	O
be	O
informative	O
about	O
negative	O
regulatory	O
circuits	O
that	O
can	O
potentially	O
limit	O
blood	O
cell	O
formation	O
.	O

We	O
used	O
expression	O
cloning	O
to	O
identify	O
interleukin-6	B-protein
(	O
IL-6	B-protein
)	O
as	O
one	O
factor	O
that	O
suppressed	O
growth	O
of	O
a	O
pre-B-cell	B-cell_line
variant	I-cell_line
line	I-cell_line
,	O
1A9-M	B-cell_line
.	O

Moreover	O
,	O
IL-6	B-protein
induced	O
macrophage-differentiation	O
and	O
apoptosis	O
of	O
1A9-M	B-cell_line
cells	I-cell_line
.	O

During	O
this	O
process	O
,	O
IL-6	B-protein
downregulated	O
expression	O
of	O
BCL2	B-protein
in	O
1A9-M	B-cell_line
cells	I-cell_line
and	O
stimulated	O
BCL-XL	O
expression	O
,	O
but	O
had	O
no	O
effect	O
on	O
p53	O
,	O
Bax	O
,	O
or	O
Bak	O
gene	O
expression	O
.	O

Mechanisms	O
for	O
transduction	O
of	O
IL-6	B-protein
-induced	O
signals	O
were	O
then	O
evaluated	O
in	O
IL-6-stimulated	B-cell_line
1A9-M	I-cell_line
cells	I-cell_line
.	O

Whereas	O
the	O
signal	B-protein
transducer	I-protein
and	I-protein
activator	I-protein
of	I-protein
transcription	I-protein
3	I-protein
(	O
Stat3	B-protein
)	O
was	O
phosphorylated	O
and	O
activated	O
,	O
there	O
was	O
no	O
effect	O
on	O
either	O
Stat1	B-protein
or	O
Stat5	B-protein
.	O

The	O
importance	O
of	O
BCL2	B-protein
and	O
Stat3	B-protein
on	O
IL-6	B-protein
-induced	O
macrophage-differentiation	O
and	O
apoptosis	O
was	O
studied	O
with	O
1A9-M	B-cell_line
cells	I-cell_line
expressing	O
human	B-protein
BCL2	I-protein
or	O
a	O
dominant-negative	O
form	O
of	O
Stat3	B-protein
,	O
respectively	O
.	O

IL-6	B-protein
-induced	O
apoptosis	O
,	O
but	O
not	O
macrophage-differentiation	O
,	O
was	O
blocked	O
by	O
continuously	O
expressed	O
BCL2	B-protein
.	O

A	O
dominant-negative	B-protein
form	I-protein
of	I-protein
Stat3	I-protein
inhibited	O
both	O
macrophage-differentiation	O
and	O
apoptosis	O
induced	O
by	O
IL-6	B-protein
.	O

However	O
,	O
diminished	O
Stat3	B-protein
activity	O
did	O
not	O
prevent	O
IL-6	B-protein
-induced	O
downregulation	O
of	O
the	O
BCL2	B-DNA
gene	I-DNA
.	O

Therefore	O
,	O
activation	O
of	O
Stat3	B-protein
is	O
essential	O
for	O
IL-6	B-protein
-induced	O
macrophage-differentiation	O
and	O
programmed	O
cell	O
death	O
in	O
this	O
model	O
.	O

Whereas	O
overexpression	O
of	O
BCL2	B-protein
abrogates	O
the	O
apoptotic	O
response	O
,	O
Stat3	B-protein
-independent	O
signals	O
appear	O
to	O
downregulate	O
expression	O
of	O
the	O
BCL2	B-DNA
gene	I-DNA
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Both	NULL
Stat3-Activation	NULL
and	NULL
Stat3-Independent	NULL
BCL2	NULL
Downregulation	NULL
Are	NULL
Important	NULL
for	NULL
Interleukin-6-Induced	NULL
Apoptosis	NULL
of	NULL
1A9-M	NULL
Cells	NULL
By	NULL
Kenji	NULL
Oritani	NULL
,	NULL
Yoshiaki	NULL
Tomiyama	NULL
,	NULL
Paul	NULL
W.	NULL
Kincade	NULL
,	NULL
Keisuke	NULL
Aoyama	NULL
,	NULL
Takafumi	NULL
Yokota	NULL
,	NULL
Itaru	NULL
Matsumura	NULL
,	NULL
Yuzuru	NULL
Kanakura	NULL
,	NULL
Koichi	NULL
Nakajima	NULL
,	NULL
Toshio	NULL
Hirano	NULL
,	NULL
and	NULL
Yuji	NULL
Matsuzawa	NULL
A	NULL
unique	NULL
subclone	NULL
of	NULL
a	NULL
bone	NULL
marrow-derived	NULL
stromal	NULL
cell	NULL
line	NULL
,	NULL
BMS2.4	NULL
,	NULL
produces	NULL
soluble	NULL
factors	NULL
that	NULL
inhibit	NULL
proliferation	NULL
of	NULL
several	NULL
types	NULL
of	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

An	NULL
understanding	NULL
of	NULL
these	NULL
molecules	NULL
may	NULL
be	NULL
informative	NULL
about	NULL
negative	NULL
regulatory	NULL
circuits	NULL
that	NULL
can	NULL
potentially	NULL
limit	NULL
blood	NULL
cell	NULL
formation	NULL
.	NULL

We	NULL
used	NULL
expression	NULL
cloning	NULL
to	NULL
identify	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
as	NULL
one	NULL
factor	NULL
that	NULL
suppressed	NULL
growth	NULL
of	NULL
a	NULL
pre-B-cell	NULL
variant	NULL
line	NULL
,	NULL
1A9-M	NULL
.	NULL

Moreover	NULL
,	NULL
IL-6	NULL
induced	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

During	NULL
this	NULL
process	NULL
,	NULL
IL-6	NULL
downregulated	NULL
expression	NULL
of	NULL
BCL2	NULL
in	NULL
1A9-M	NULL
cells	NULL
and	NULL
stimulated	NULL
BCL-XL	NULL
expression	NULL
,	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
p53	NULL
,	NULL
Bax	NULL
,	NULL
or	NULL
Bak	NULL
gene	NULL
expression	NULL
.	NULL

Mechanisms	NULL
for	NULL
transduction	NULL
of	NULL
IL-6-induced	NULL
signals	NULL
were	NULL
then	NULL
evaluated	NULL
in	NULL
IL-6-stimulated	NULL
1A9-M	NULL
cells	NULL
.	NULL

Whereas	NULL
the	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
3	NULL
(	NULL
Stat3	NULL
)	NULL
was	NULL
phosphorylated	NULL
and	NULL
activated	NULL
,	NULL
there	NULL
was	NULL
no	NULL
effect	NULL
on	NULL
either	NULL
Stati	NULL
or	NULL
Stat5	NULL
.	NULL

LOOD	NULL
CELL	NULL
FORMATION	NULL
is	NULL
strictly	NULL
regulated	NULL
by	NULL
the	NULL
bone	NULL
marrow	NULL
microenvironmental	NULL
factors	NULL
,	NULL
including	NULL
adhesion	NULL
molecules	NULL
,	NULL
extracellular	NULL
matrix	NULL
components	NULL
,	NULL
and	NULL
cyto-kines	NULL
.	NULL
'	NULL

''	NULL
Interactions	NULL
between	NULL
very	NULL
late	NULL
antigen	NULL
4	NULL
and	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
and	NULL
between	NULL
CD44	NULL
and	NULL
hyaluronan	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
,	NULL
because	NULL
antibodies	NULL
against	NULL
them	NULL
blocked	NULL
the	NULL
production	NULL
of	NULL
lymphoid	NULL
and/or	NULL
myeloid	NULL
cells	NULL
in	NULL
long-term	NULL
bone	NULL
marrow	NULL
cultures	NULL
.	NULL
``	NULL

Modification	NULL
of	NULL
cell-cell	NULL
adhesion	NULL
by	NULL
an	NULL
antibody	NULL
against	NULL
CD9	NULL
also	NULL
blocked	NULL
production	NULL
of	NULL
myeloid	NULL
cells	NULL
in	NULL
Dexter	NULL
cultures	NULL
.	NULL
``	NULL

Regulatory	NULL
cytokines	NULL
in	NULL
bone	NULL
marrow	NULL
are	NULL
typically	NULL
produced	NULL
in	NULL
extremely	NULL
small	NULL
quantities	NULL
,	NULL
and	NULL
some	NULL
of	NULL
them	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
extracellular	NULL
matrix	NULL
.	NULL
``	NULL

A	NULL
number	NULL
of	NULL
genes	NULL
that	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
lympho-hematopoiesis	NULL
have	NULL
been	NULL
identified	NULL
by	NULL
experiments	NULL
using	NULL
cloned	NULL
stromal	NULL
cell	NULL
lines	NULL
that	NULL
were	NULL
originally	NULL
selected	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
support	NULL
proliferation	NULL
and/or	NULL
differentiation	NULL
of	NULL
a	NULL
particular	NULL
type	NULL
of	NULL
hematopoietic	NULL
cells	NULL
.	NULL

A	NULL
stromal	NULL
cell	NULL
line	NULL
,	NULL
BMS2	NULL
,	NULL
which	NULL
was	NULL
established	NULL
from	NULL
adherent	NULL
cells	NULL
of	NULL
long-term	NULL
bone	NULL
marrow	NULL
cultures	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
support	NULL
growth	NULL
of	NULL
pre-B	NULL
cells	NULL
.	NULL
``	NULL

However	NULL
,	NULL
BMS2.4	NULL
,	NULL
a	NULL
subclone	NULL
of	NULL
BMS2	NULL
,	NULL
has	NULL
unique	NULL
characteristics	NULL
.	NULL

It	NULL
blocked	NULL
proliferation	NULL
of	NULL
certain	NULL
types	NULL
of	NULL
hematopoietic	NULL
cells	NULL
selectively	NULL
and	NULL
interacted	NULL
with	NULL
the	NULL
pH	NULL
From	NULL
The	NULL
Second	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
The	NULL
Department	NULL
of	NULL
Hematology/Oncology	NULL
,	NULL
and	NULL
The	NULL
Department	NULL
of	NULL
Molecular	NULL
Oncology	NULL
,	NULL
Biomedical	NULL
Research	NULL
Center	NULL
,	NULL
Osaka	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
the	NULL
Oklahoma	NULL
Medical	NULL
Research	NULL
Foundation	NULL
,	NULL
Oklahoma	NULL
City	NULL
,	NULL
OK	NULL
.	NULL

Submitted	NULL
April	NULL
28	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
October	NULL
9	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Culture	NULL
,	NULL
and	NULL
the	NULL
Japan	NULL
Society	NULL
for	NULL
the	NULL
Promotion	NULL
of	NULL
Science	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Kenji	NULL
Oritani	NULL
,	NULL
MD	NULL
,	NULL
The	NULL
Second	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Osaka	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
2-2	NULL
Yamada-oka	NULL
,	NULL
Suita	NULL
City	NULL
,	NULL
Osaka	NULL
565	NULL
,	NULL
Japan	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/99/9304-0015	NULL
$	NULL
3.00/0	NULL
1346	NULL
The	NULL
importance	NULL
of	NULL
BCL2	NULL
and	NULL
Stat3	NULL
on	NULL
IL-6-induced	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
w	NULL
as	NULL
studied	NULL
w	NULL
ith	NULL
1A9-M	NULL
cells	NULL
expressing	NULL
human	NULL
BCL2	NULL
or	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
Stat3	NULL
,	NULL
respectively	NULL
.	NULL

IL-6-induced	NULL
apoptosis	NULL
,	NULL
but	NULL
not	NULL
macro-phage-differentiation	NULL
,	NULL
was	NULL
blocked	NULL
by	NULL
continuously	NULL
expressed	NULL
BCL2	NULL
.	NULL

A	NULL
dominant-negative	NULL
form	NULL
of	NULL
Stat3	NULL
inhibited	NULL
both	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
induced	NULL
by	NULL
IL-6	NULL
.	NULL

However	NULL
,	NULL
diminished	NULL
Stat3	NULL
activity	NULL
did	NULL
not	NULL
prevent	NULL
IL-6-induced	NULL
downregulation	NULL
of	NULL
the	NULL
BCL2	NULL
gene	NULL
.	NULL

Therefore	NULL
,	NULL
activation	NULL
of	NULL
Stat3	NULL
is	NULL
essential	NULL
for	NULL
IL-6-induced	NULL
macrophage-differentiation	NULL
and	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
this	NULL
model	NULL
.	NULL

Whereas	NULL
overexpression	NULL
of	NULL
BCL2	NULL
abrogates	NULL
the	NULL
apoptotic	NULL
response	NULL
,	NULL
Stat3-independent	NULL
signals	NULL
appear	NULL
to	NULL
dow	NULL
late	NULL
expression	NULL
of	NULL
the	NULL
BCL2	NULL
gene	NULL
.	NULL

Â©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

indicator	NULL
,	NULL
phenol	NULL
red	NULL
.	NULL
``	NULL

We	NULL
now	NULL
report	NULL
that	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
is	NULL
one	NULL
of	NULL
the	NULL
growth-suppressors	NULL
produced	NULL
by	NULL
BMS2.4	NULL
cells	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-6	NULL
as	NULL
well	NULL
as	NULL
the	NULL
supernatant	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
mouse	NULL
IL-6	NULL
cDNA	NULL
induced	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
of	NULL
1A9-M	NULL
cells	NULL
,	NULL
a	NULL
variant	NULL
1A9	NULL
pre-B-cell	NULL
line	NULL
.	NULL

IL-6	NULL
is	NULL
a	NULL
multifunctional	NULL
cytokine	NULL
that	NULL
regulates	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cells	NULL
.	NULL

!	NULL
``	NULL

IL-6	NULL
induces	NULL
terminal	NULL
differentiation	NULL
of	NULL
B	NULL
cells	NULL
to	NULL
antibody-producing	NULL
cells	NULL
,	NULL
proliferation	NULL
of	NULL
myeloma	NULL
cells	NULL
,	NULL
and	NULL
production	NULL
of	NULL
acute-phase	NULL
proteins	NULL
by	NULL
hepatocytes	NULL
.	NULL
``	NULL

IL-6	NULL
also	NULL
induces	NULL
macrophage	NULL
differentiation	NULL
of	NULL
several	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
M1	NULL
and	NULL
Y6	NULL
.	NULL

``	NULL
*	NULL
``	NULL
Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
IL-6	NULL
induced	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
signal	NULL
transduction	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
Janus	NULL
kinases	NULL
(	NULL
JAK1	NULL
,	NULL
JAK2	NULL
,	NULL
and	NULL
Tyk2	NULL
)	NULL
and	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
family	NULL
proteins	NULL
(	NULL
Statl	NULL
and	NULL
Stat3	NULL
)	NULL
.	NULL
'	NULL

%	NULL
``	NULL
In	NULL
particular	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
Stat3	NULL
molecule	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
IL-6-induced	NULL
macrophage-differentiation	NULL
of	NULL
M1	NULL
cells	NULL
.	NULL

?	NULL
``	NULL

We	NULL
describe	NULL
here	NULL
two	NULL
IL-6-induced	NULL
signal	NULL
transduction	NULL
pathways	NULL
that	NULL
lead	NULL
to	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

A	NULL
stromal	NULL
cell	NULL
line	NULL
BMS2	NULL
and	NULL
its	NULL
subclone	NULL
,	NULL
BMS2.4	NULL
,	NULL
were	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
Flow	NULL
Laboratories	NULL
,	NULL
North	NULL
Ryde	NULL
,	NULL
Australia	NULL
)	NULL
.	NULL

1A9	NULL
,	NULL
a	NULL
pre-B-cell	NULL
line	NULL
,	NULL
and	NULL
its	NULL
variant	NULL
line	NULL
,	NULL
designated	NULL
1A9-M	NULL
,	NULL
were	NULL
cultured	NULL
in	NULL
McCoy	NULL
's	NULL
5A	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FCS	NULL
and	NULL
5	NULL
X	NULL
107	NULL
``	NULL
mol/L	NULL
2-mercaptoethanol	NULL
.	NULL
``	NULL

The	NULL
1A9-M	NULL
line	NULL
has	NULL
rearranged	NULL
both	NULL
JH	NULL
alleles	NULL
.	NULL

However	NULL
,	NULL
one	NULL
JH	NULL
allele	NULL
is	NULL
different	NULL
from	NULL
the	NULL
original	NULL
1A9	NULL
line	NULL
and	NULL
therefore	NULL
may	NULL
have	NULL
undergone	NULL
a	NULL
secondary	NULL
rearrangement	NULL
.	NULL

1A9-M	NULL
has	NULL
also	NULL
lost	NULL
expression	NULL
of	NULL
IgM	NULL
and	NULL
CD19	NULL
.	NULL

Lymphoma	NULL
cell	NULL
lines	NULL
(	NULL
7OZ/3	NULL
and	NULL
EL4	NULL
)	NULL
,	NULL
an	NULL
IL-3-dependent	NULL
pro-B-cell	NULL
line	NULL
(	NULL
BaF3	NULL
)	NULL
,	NULL
and	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
(	NULL
FDCP1	NULL
and	NULL
WEHI3	NULL
)	NULL
were	NULL
maintained	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

*	NULL
To	NULL
make	NULL
stable	NULL
transformants	NULL
of	NULL
1A9-M	NULL
cells	NULL
expressing	NULL
human	NULL
BCL2	NULL
or	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
Stat3	NULL
,	NULL
pSVBT	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
Y.	NULL
Tsujimoto	NULL
,	NULL
Osaka	NULL
University	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
or	NULL
pCAGGS-Neo-HA-Stat3DÂ®	NULL
'	NULL
were	NULL
transfected	NULL
into	NULL
1A9-M	NULL
cells	NULL
by	NULL
electroporation	NULL
and	NULL
the	NULL
Blood	NULL
,	NULL
Vol	NULL
93	NULL
,	NULL
No	NULL
4	NULL
(	NULL
February	NULL
15	NULL
)	NULL
,	NULL
1999	NULL
;	NULL
pp	NULL
1346-1354	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MACROPHAGE	NULL
DIFFERENTIATION	NULL
AND	NULL
APOPTOSIS	NULL
transformants	NULL
were	NULL
selected	NULL
with	NULL
1	NULL
mg/mL	NULL
of	NULL
G418	NULL
(	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Expression	NULL
cloning	NULL
and	NULL
sequence	NULL
analysis	NULL
.	NULL

|	NULL
Polyadenylated	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
BMS2.4	NULL
cells	NULL
using	NULL
a	NULL
Fast	NULL
Track	NULL
mRNA	NULL
isolation	NULL
kit	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Double-stranded	NULL
cDNA	NULL
was	NULL
synthesized	NULL
with	NULL
a	NULL
TimeSaver	NULL
cDNA	NULL
synthesis	NULL
kit	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
,	NULL
ligated	NULL
with	NULL
BstXI	NULL
adaptors	NULL
(	NULL
Invitrogen	NULL
)	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
a	NULL
mammalian	NULL
expression	NULL
vector	NULL
,	NULL
pEF-BOS	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
S.	NULL
Nagata	NULL
,	NULL
Osaka	NULL
Bioscience	NULL
Institute	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Plasmid	NULL
cDNAs	NULL
were	NULL
purified	NULL
from	NULL
pools	NULL
of	NULL
a	NULL
few	NULL
hundreds	NULL
of	NULL
clones	NULL
and	NULL
were	NULL
transfected	NULL
into	NULL
293T	NULL
cells	NULL
by	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
.	NULL

Supernatants	NULL
from	NULL
each	NULL
transfectant	NULL
were	NULL
added	NULL
to	NULL
cultures	NULL
of	NULL
1A9-M	NULL
cells	NULL
,	NULL
and	NULL
positive	NULL
pools	NULL
were	NULL
identified	NULL
by	NULL
growth	NULL
suppression	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

Positive	NULL
pools	NULL
were	NULL
divided	NULL
into	NULL
progressively	NULL
smaller	NULL
pools	NULL
and	NULL
rescreened	NULL
until	NULL
single	NULL
clones	NULL
were	NULL
isolated	NULL
.	NULL

The	NULL
inserts	NULL
of	NULL
the	NULL
single	NULL
clones	NULL
were	NULL
subcloned	NULL
into	NULL
pBluescript	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
nucleotide	NULL
sequence	NULL
was	NULL
determined	NULL
using	NULL
an	NULL
automated	NULL
DNA	NULL
sequencer	NULL
(	NULL
Applied	NULL
Biosys-tems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Nucleotide	NULL
data	NULL
base	NULL
searching	NULL
was	NULL
performed	NULL
with	NULL
BLAST	NULL
from	NULL
the	NULL
GCG	NULL
computer	NULL
program	NULL
(	NULL
Genetics	NULL
Computer	NULL
Group	NULL
,	NULL
Madison	NULL
,	NULL
WD	NULL
.	NULL

Flow	NULL
cytometry	NULL
.	NULL

Antibody	NULL
incubations	NULL
and	NULL
washing	NULL
steps	NULL
were	NULL
performed	NULL
at	NULL
4Â°C	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
containing	NULL
3	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
and	NULL
0.1	NULL
%	NULL
sodium	NULL
azide	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Antibodies	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
fluorescein	NULL
isothiocya-nate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
antimouse	NULL
CD32/CD16	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
-conjugated	NULL
antimouse	NULL
F4/80	NULL
(	NULL
Caltag	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Isotype-matched	NULL
Igs	NULL
were	NULL
used	NULL
for	NULL
controls	NULL
.	NULL

Cell	NULL
cycle	NULL
analysis	NULL
.	NULL

-	NULL
After	NULL
stimulation	NULL
,	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10Â°	NULL
)	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
100	NULL
uL	NULL
of	NULL
PBS	NULL
,	NULL
and	NULL
fixed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
900	NULL
uL	NULL
of	NULL
cold	NULL
ethanol	NULL
.	NULL

The	NULL
fixed	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
300	NULL
uL	NULL
of	NULL
staining	NULL
buffer	NULL
(	NULL
1	NULL
mg/mL	NULL
RNase	NULL
,	NULL
20	NULL
ug/mL	NULL
propidium	NULL
iodide	NULL
,	NULL
and	NULL
0.01	NULL
%	NULL
NP-40	NULL
in	NULL
PBS	NULL
)	NULL
at	NULL
37Â°C	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
DNA	NULL
contents	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
analyzed	NULL
with	NULL
FACSort	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
using	NULL
Cell	NULL
Quest	NULL
software	NULL
.	NULL

DNA	NULL
fragmentation	NULL
assay	NULL
.	NULL

-	NULL
Fragmentation	NULL
of	NULL
DNA	NULL
was	NULL
assayed	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

''	NULL
After	NULL
stimulation	NULL
with	NULL
IL-6	NULL
,	NULL
1A9-M	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
lysed	NULL
in	NULL
0.4	NULL
mL	NULL
lysis	NULL
buffer	NULL
containing	NULL
200	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
100	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
and	NULL
50	NULL
ug/mL	NULL
proteinase	NULL
K	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
4	NULL
hours	NULL
at	NULL
37Â°C	NULL
.	NULL

DNAs	NULL
were	NULL
extracted	NULL
with	NULL
phenol	NULL
and	NULL
then	NULL
with	NULL
chloroform/isoamylalcohol	NULL
.	NULL

The	NULL
aqueous	NULL
phase	NULL
was	NULL
collected	NULL
and	NULL
precipitated	NULL
with	NULL
NaCl	NULL
and	NULL
ethanol	NULL
.	NULL

DNA	NULL
pellets	NULL
were	NULL
suspended	NULL
in	NULL
0.4	NULL
mL	NULL
TE	NULL
buffer	NULL
and	NULL
treated	NULL
with	NULL
50	NULL
ug/mL	NULL
RNase	NULL
for	NULL
5	NULL
hours	NULL
and	NULL
then	NULL
with	NULL
200	NULL
ug/mL	NULL
proteinase	NULL
K	NULL
for	NULL
5	NULL
hours	NULL
.	NULL

DNAs	NULL
were	NULL
extracted	NULL
twice	NULL
and	NULL
precipitated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

DNA	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
TE	NULL
buffer	NULL
,	NULL
separated	NULL
by	NULL
electrophore-sis	NULL
in	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
(	NULL
1	NULL
ug	NULL
DNA	NULL
per	NULL
lane	NULL
)	NULL
,	NULL
stained	NULL
with	NULL
0.5	NULL
ug/mL	NULL
ethidium	NULL
bromide	NULL
,	NULL
and	NULL
visualized	NULL
under	NULL
UV	NULL
light	NULL
.	NULL

Luciferase	NULL
assay	NULL
.	NULL

A	NULL
luciferase	NULL
construct	NULL
,	NULL
4X	NULL
APRE-Luc	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
Stat3-binding	NULL
sequence	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reporter	NULL
gene	NULL
.	NULL
``	NULL

Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
Dual-Luciferase	NULL
Reporter	NULL
System	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
in	NULL
which	NULL
transfection	NULL
efficiency	NULL
was	NULL
monitored	NULL
by	NULL
cotransfected	NULL
pRL-CMV-Rluc	NULL
,	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
renilla	NULL
luciferase	NULL
.	NULL

The	NULL
cultured	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
reporter	NULL
gene	NULL
together	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
pRL-CMV-Rluc	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
serum-starved	NULL
for	NULL
12	NULL
hours	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
20	NULL
ng/mL	NULL
IL-6	NULL
for	NULL
5	NULL
hours	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
supplied	NULL
by	NULL
the	NULL
manufactuer	NULL
,	NULL
followed	NULL
by	NULL
measurement	NULL
of	NULL
the	NULL
firefly	NULL
and	NULL
the	NULL
renilla	NULL
luciferase	NULL
activities	NULL
on	NULL
luminometer	NULL
LB96P	NULL
(	NULL
Berthold	NULL
Japan	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
firefly	NULL
luciferase	NULL
activities	NULL
were	NULL
calculated	NULL
by	NULL
normalizing	NULL
transfection	NULL
efficiency	NULL
according	NULL
to	NULL
the	NULL
renilla	NULL
luciferase	NULL
activities	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
isolated	NULL
using	NULL
TRIzol	NULL
Reagent	NULL
(	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
electrophoresed	NULL
through	NULL
a	NULL
formaldehyde	NULL
agarose	NULL
gel	NULL
,	NULL
and	NULL
transferred	NULL
onto	NULL
a	NULL
nylon	NULL
membrane	NULL
1347	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
fragments	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
Â°Â°P	NULL
]	NULL
dCTP	NULL
using	NULL
a	NULL
random	NULL
primed	NULL
DNA	NULL
labeling	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
and	NULL
hybridized	NULL
to	NULL
the	NULL
membrane	NULL
.	NULL

Blots	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
autoradiographed	NULL
.	NULL

Fragments	NULL
of	NULL
the	NULL
BCL2	NULL
,	NULL
BCL-XL	NULL
,	NULL
Bak	NULL
,	NULL
Bax	NULL
,	NULL
p53	NULL
,	NULL
and	NULL
B-actin	NULL
genes	NULL
were	NULL
used	NULL
as	NULL
materials	NULL
for	NULL
probes	NULL
.	NULL
``	NULL

Western	NULL
blot	NULL
analysis	NULL
.	NULL

-	NULL
The	NULL
isolation	NULL
of	NULL
cellular	NULL
lysates	NULL
,	NULL
gel	NULL
electro-phoresis	NULL
,	NULL
and	NULL
immunoblotting	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
methods	NULL
described	NULL
previously	NULL
,	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
1A9-M	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
insoluble	NULL
material	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
.	NULL

Whole	NULL
cellular	NULL
lysates	NULL
(	NULL
15	NULL
ug	NULL
per	NULL
each	NULL
lane	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
electrophoretically	NULL
transferred	NULL
onto	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
(	NULL
Immobilon	NULL
;	NULL
Millipore	NULL
Corp	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

After	NULL
blocking	NULL
the	NULL
residual	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
filter	NULL
,	NULL
immunoblotting	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
appropriate	NULL
antibody	NULL
.	NULL

Immunoreactive	NULL
proteins	NULL
were	NULL
then	NULL
visualized	NULL
with	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
DuPont	NULL
NEN	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

A	NULL
mouse	NULL
antihuman	NULL
BCL2	NULL
antibody	NULL
,	NULL
a	NULL
mouse	NULL
antimouse	NULL
BCL2	NULL
antibody	NULL
,	NULL
and	NULL
a	NULL
rabbit	NULL
antimouse	NULL
BCL-X	NULL
antibody	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

RESULTS	NULL
Supernatant	NULL
of	NULL
BMS2.4	NULL
suppressed	NULL
growth	NULL
of	NULL
certain	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

-	NULL
BMS2.4	NULL
is	NULL
an	NULL
unique	NULL
subclone	NULL
of	NULL
the	NULL
BMS2	NULL
stromal	NULL
cell	NULL
line	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
parent	NULL
line	NULL
that	NULL
supports	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
precursors	NULL
,	NULL
BMS2.4	NULL
inhibits	NULL
the	NULL
growth	NULL
of	NULL
some	NULL
hematopoietic	NULL
cell	NULL
types	NULL
.	NULL
``	NULL

We	NULL
evaluated	NULL
whether	NULL
these	NULL
inhibitory	NULL
effects	NULL
were	NULL
mediated	NULL
by	NULL
soluble	NULL
factors	NULL
or	NULL
cell	NULL
surface	NULL
molecules	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
,	NULL
proliferation	NULL
of	NULL
several	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
(	NULL
1A9	NULL
,	NULL
70Z/3	NULL
,	NULL
1A9-M	NULL
,	NULL
and	NULL
WEHI3	NULL
)	NULL
was	NULL
suppressed	NULL
by	NULL
BMS2.4	NULL
conditioned	NULL
medium	NULL
,	NULL
whereas	NULL
that	NULL
of	NULL
FDCP1	NULL
,	NULL
BaF3	NULL
,	NULL
and	NULL
EL4	NULL
cell	NULL
lines	NULL
was	NULL
not	NULL
affected	NULL
.	NULL

Supernatants	NULL
derived	NULL
from	NULL
the	NULL
parent	NULL
BMS2	NULL
line	NULL
were	NULL
not	NULL
suppressive	NULL
for	NULL
any	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

The	NULL
1A9-M	NULL
cells	NULL
appeared	NULL
to	NULL
be	NULL
particularly	NULL
sensitive	NULL
to	NULL
inhibition	NULL
by	NULL
BMS2.4	NULL
and	NULL
were	NULL
used	NULL
in	NULL
subsequent	NULL
attempts	NULL
to	NULL
identify	NULL
inhibitory	NULL
factors	NULL
.	NULL

The	NULL
growth-inhibitory	NULL
activity	NULL
was	NULL
not	NULL
blocked	NULL
by	NULL
neutralizing	NULL
antibodies	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
,	NULL
tumor	NULL
growth	NULL
factor-	NULL
,	NULL
or	NULL
interferon-	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

BMS2	NULL
sup	NULL
BMS2.4	NULL
sup	NULL
Recovered	NULL
Cell	NULL
Number	NULL
(	NULL
x1000	NULL
)	NULL
1A9M	NULL
_	NULL
1a9	NULL
107	NULL
%	NULL
/3	NULL
BaF	NULL
3	NULL
Cell	NULL
Line	NULL
FDCP1	NULL
-	NULL
WEHL3	NULL
EL	NULL
4	NULL
Fig	NULL
1	NULL
.	NULL

Growth	NULL
inhibitory	NULL
effects	NULL
of	NULL
BMS2.4	NULL
supernatant	NULL
on	NULL
various	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
indicated	NULL
cell	NULL
lines	NULL
(	NULL
1	NULL
x	NULL
10	NULL
%	NULL
cells/well	NULL
)	NULL
were	NULL
cultured	NULL
with	NULL
supernatant	NULL
of	NULL
BM	NULL
S2	NULL
or	NULL
BMS2.4	NULL
cells	NULL
for	NULL
48	NULL
hours	NULL
and	NULL
number	NULL
of	NULL
remaining	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
hemocytometer	NULL
counts	NULL
.	NULL

The	NULL
results	NULL
are	NULL
show	NULL
n	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
cultures	NULL
.	NULL

Statistically	NULL
significant	NULL
differences	NULL
from	NULL
control	NULL
values	NULL
are	NULL
indicated	NULL
:	NULL
*P	NULL
<	NULL
.05	NULL
;	NULL
**P	NULL
<	NULL
.01	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1348	NULL
Table	NULL
1	NULL
.	NULL

A	NULL
Summary	NULL
for	NULL
the	NULL
Expression	NULL
Cloning	NULL
%	NULL
Growth	NULL
Suppression	NULL
Insert	NULL
Clone	NULL
of	NULL
1A9-M	NULL
Cells	NULL
Length	NULL
(	NULL
bp	NULL
)	NULL
Sequence	NULL
of	NULL
Insert	NULL
Clone	NULL
84	NULL
95.2	NULL
+	NULL
2.12	NULL
1,050	NULL
Mouse	NULL
IL-6	NULL
Clone	NULL
120	NULL
93.5	NULL
+	NULL
1.69	NULL
2,100	NULL
Mouse	NULL
IL-6	NULL
Clone	NULL
166	NULL
96.9	NULL
+	NULL
3.91	NULL
1,100	NULL
Mouse	NULL
IL-6	NULL
Clone	NULL
217	NULL
95.1	NULL
+	NULL
2.24	NULL
1,050	NULL
Mouse	NULL
IL-6	NULL
Clone	NULL
255	NULL
91.8	NULL
+	NULL
4.75	NULL
1,000	NULL
Mouse	NULL
IL-6	NULL
Clone	NULL
283	NULL
95.5	NULL
+	NULL
6.23	NULL
1,000	NULL
Mouse	NULL
IL-6	NULL
An	NULL
expression	NULL
library	NULL
was	NULL
made	NULL
from	NULL
BMS2.4	NULL
cells	NULL
.	NULL

Approximately	NULL
1.2	NULL
X	NULL
105	NULL
clones	NULL
were	NULL
screened	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
growth	NULL
inhibition	NULL
of	NULL
1A9-M	NULL
cells	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
and	NULL
6	NULL
clones	NULL
were	NULL
isolated	NULL
.	NULL

Plasmids	NULL
from	NULL
each	NULL
positive	NULL
clone	NULL
were	NULL
transfected	NULL
into	NULL
293T	NULL
cells	NULL
,	NULL
and	NULL
supernatants	NULL
of	NULL
the	NULL
transfectants	NULL
were	NULL
collected	NULL
after	NULL
3	NULL
days	NULL
of	NULL
incubation	NULL
.	NULL

1A9-M	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
the	NULL
supernatants	NULL
for	NULL
3	NULL
days	NULL
,	NULL
and	NULL
recovered	NULL
viable	NULL
cells	NULL
were	NULL
measured	NULL
by	NULL
hemocytometer	NULL
.	NULL

The	NULL
nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
inserts	NULL
from	NULL
the	NULL
single	NULL
clones	NULL
were	NULL
determined	NULL
using	NULL
an	NULL
automated	NULL
DNA	NULL
sequencer	NULL
.	NULL

Identification	NULL
of	NULL
IL-6	NULL
as	NULL
one	NULL
inhibitory	NULL
cytokine	NULL
secreted	NULL
by	NULL
BMS2.4	NULL
cells	NULL
.	NULL

Expression	NULL
cloning	NULL
of	NULL
growth	NULL
inhibitory	NULL
substances	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Approximately	NULL
1.2	NULL
X	NULL
10Â°	NULL
clones	NULL
of	NULL
the	NULL
BMS2.4	NULL
expression	NULL
library	NULL
were	NULL
screened	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
growth	NULL
inhibition	NULL
of	NULL
1A9-M	NULL
cells	NULL
,	NULL
and	NULL
6	NULL
clones	NULL
were	NULL
isolated	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Supernatants	NULL
of	NULL
293T	NULL
cells	NULL
that	NULL
were	NULL
transfected	NULL
with	NULL
plasmids	NULL
prepared	NULL
from	NULL
these	NULL
clones	NULL
showed	NULL
more	NULL
than	NULL
90	NULL
%	NULL
suppression	NULL
of	NULL
proliferation	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

Sequencing	NULL
showed	NULL
that	NULL
all	NULL
6	NULL
clones	NULL
contained	NULL
mouse	NULL
IL-6	NULL
cDNA	NULL
inserts	NULL
.	NULL

Moreover	NULL
,	NULL
proliferation	NULL
of	NULL
1A9-M	NULL
cells	NULL
was	NULL
suppressed	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
when	NULL
recombinant	NULL
human	NULL
IL-6	NULL
was	NULL
added	NULL
to	NULL
cultures	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
a	NULL
neutralizing	NULL
antibody	NULL
to	NULL
mouse	NULL
IL-6	NULL
(	NULL
Genzyme	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
cancelled	NULL
approximately	NULL
90	NULL
%	NULL
of	NULL
the	NULL
growth	NULL
inhibitory	NULL
effect	NULL
of	NULL
BMS2.4	NULL
supernatant	NULL
on	NULL
1A9-M	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-6	NULL
represents	NULL
one	NULL
major	NULL
substance	NULL
produced	NULL
by	NULL
BMS2.4	NULL
cells	NULL
that	NULL
can	NULL
arrest	NULL
growth	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

IL-6	NULL
induced	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

1A9-M	NULL
cells	NULL
typically	NULL
have	NULL
blastoid	NULL
features	NULL
with	NULL
basophilic	NULL
cytoplasm	NULL
and	NULL
large	NULL
nuclei	NULL
containing	NULL
nucleoli	NULL
(	NULL
Fig	NULL
3A	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
and	NULL
are	NULL
negative	NULL
for	NULL
CD45RA	NULL
,	NULL
Macl	NULL
A	NULL
|	NULL
2007	NULL
B	NULL
s	NULL
Â»	NULL
@	NULL
Medium	NULL
A	NULL
IL-6	NULL
20ng/ml	NULL
2007	NULL
200	NULL
7	NULL
100	NULL
7	NULL
Recovered	NULL
Cell	NULL
Number	NULL
(	NULL
x1000	NULL
)	NULL
Recovered	NULL
Cell	NULL
Number	NULL
(	NULL
x1000	NULL
)	NULL
o	NULL
r	NULL
r	NULL
r	NULL
gir	NULL
r	NULL
r	NULL
r	NULL
o	NULL
1	NULL
2	NULL
3	NULL
0	NULL
0.2	NULL
2	NULL
Culture	NULL
(	NULL
Days	NULL
)	NULL
Concentration	NULL
of	NULL
IL-6	NULL
(	NULL
ng/ml	NULL
)	NULL
ORITANI	NULL
ET	NULL
AL	NULL
Medium	NULL
IL-6	NULL
(	NULL
48	NULL
hours	NULL
)	NULL
Medium	NULL
IL-6	NULL
(	NULL
24	NULL
hours	NULL
)	NULL
CD32/CD16	NULL
F4/80	NULL
Relative	NULL
Cell	NULL
Number	NULL
1	NULL
3	NULL
10	NULL
)	NULL
ant	NULL
aod	NULL
ant	NULL
10Â°	NULL
ao	NULL
``	NULL
ao	NULL
Fluorescence	NULL
Intensity	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
IL-6-induced	NULL
macrophage-differentiation	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
1A9-M	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
or	NULL
without	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
20	NULL
ng/	NULL
mL	NULL
IL-6	NULL
for	NULL
48	NULL
hours	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
cytospin	NULL
,	NULL
stained	NULL
by	NULL
May-Grunwald-Giemsa	NULL
,	NULL
and	NULL
photographed	NULL
at	NULL
1,000	NULL
%	NULL
x	NULL
magnifica-tion	NULL
.	NULL

(	NULL
B	NULL
)	NULL
1A9-M	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
20	NULL
ng/mL	NULL
IL-6	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

Surface	NULL
expression	NULL
of	NULL
CD32/	NULL
CD16	NULL
and	NULL
a	NULL
F4/80	NULL
antigen	NULL
was	NULL
evaluated	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

(	NULL
CD18/11b	NULL
)	NULL
,	NULL
GR-1	NULL
,	NULL
and	NULL
TER119	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
IL-6	NULL
,	NULL
1A9-M	NULL
cells	NULL
showed	NULL
macrophage-like	NULL
morphologies	NULL
,	NULL
characterized	NULL
by	NULL
ample	NULL
vacuolated	NULL
cytoplasm	NULL
and	NULL
irregularly	NULL
shaped	NULL
nuclei	NULL
(	NULL
Fig	NULL
3A	NULL
,	NULL
right	NULL
pannel	NULL
)	NULL
.	NULL

They	NULL
Fig	NULL
2	NULL
.	NULL

IL-6-induced	NULL
growth	NULL
inhibition	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
1A9-M	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
20	NULL
ng/mL	NULL
IL-6	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
.	NULL

(	NULL
B	NULL
)	NULL
1A9-M	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
IL-6	NULL
for	NULL
3	NULL
days	NULL
.	NULL

The	NULL
results	NULL
of	NULL
hemocytometer	NULL
counts	NULL
are	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
cultures	NULL
.	NULL

20	NULL
200	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MACROPHAGE	NULL
DIFFERENTIATION	NULL
AND	NULL
APOPTOSIS	NULL
began	NULL
to	NULL
express	NULL
Fc	NULL
receptor	NULL
(	NULL
CD32/CD16	NULL
)	NULL
and	NULL
a	NULL
F4/80	NULL
antigen	NULL
,	NULL
a	NULL
macrophage-specific	NULL
antigen	NULL
,	NULL
after	NULL
IL-6	NULL
treatment	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

1A9-M	NULL
cells	NULL
started	NULL
to	NULL
die	NULL
within	NULL
48	NULL
hours	NULL
of	NULL
culture	NULL
with	NULL
IL-6	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

To	NULL
clarify	NULL
the	NULL
mechanism	NULL
of	NULL
cell	NULL
death	NULL
,	NULL
nuclear	NULL
DNA	NULL
contents	NULL
of	NULL
1	NULL
A9-M	NULL
cells	NULL
cultured	NULL
with	NULL
IL-6	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4B	NULL
,	NULL
the	NULL
proportion	NULL
of	NULL
GO-G1	NULL
population	NULL
increased	NULL
within	NULL
24	NULL
hours	NULL
(	NULL
36.8	NULL
%	NULL
before	NULL
stimulation	NULL
;	NULL
46.4	NULL
%	NULL
24	NULL
hours	NULL
after	NULL
stimulation	NULL
)	NULL
,	NULL
and	NULL
the	NULL
subdiploid	NULL
peak	NULL
appeared	NULL
within	NULL
48	NULL
hours	NULL
(	NULL
0.2	NULL
%	NULL
before	NULL
stimulation	NULL
;	NULL
43.17	NULL
%	NULL
48	NULL
hours	NULL
after	NULL
stimulation	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
DNA	NULL
obtained	NULL
from	NULL
1A9-M	NULL
cells	NULL
cultured	NULL
with	NULL
IL-6	NULL
for	NULL
more	NULL
than	NULL
48	NULL
hours	NULL
showed	NULL
extensive	NULL
degradation	NULL
with	NULL
oligonucleosomal	NULL
fragments	NULL
(	NULL
Fig	NULL
4C	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
IL-6	NULL
induces	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

Whereas	NULL
growth	NULL
of	NULL
a	NULL
related	NULL
pre-B-cell	NULL
line	NULL
,	NULL
1A9	NULL
,	NULL
was	NULL
sensitive	NULL
to	NULL
factors	NULL
produced	NULL
by	NULL
BMS2.4	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
,	NULL
they	NULL
were	NULL
not	NULL
influenced	NULL
in	NULL
any	NULL
obvious	NULL
way	NULL
by	NULL
IL-6	NULL
.	NULL

IL-6	NULL
modulated	NULL
expression	NULL
of	NULL
apoptosis-related	NULL
genes	NULL
.	NULL

To	NULL
investigate	NULL
molecular	NULL
mechanisms	NULL
involved	NULL
in	NULL
1A9-M	NULL
cell	NULL
responses	NULL
to	NULL
IL-6	NULL
,	NULL
we	NULL
evaluated	NULL
expression	NULL
of	NULL
some	NULL
apoptosis-related	NULL
genes	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
5A	NULL
,	NULL
1A9-M	NULL
cells	NULL
constitutively	NULL
expressed	NULL
BCL2	NULL
and	NULL
Bax	NULL
genes	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
BCL2	NULL
gene	NULL
was	NULL
downregulated	NULL
within	NULL
24	NULL
hours	NULL
after	NULL
stimulation	NULL
with	NULL
IL-6	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
BCL-XL	NULL
gene	NULL
was	NULL
induced	NULL
by	NULL
IL-6	NULL
treatment	NULL
.	NULL

Expression	NULL
of	NULL
Bax	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
IL-6	NULL
and	NULL
neither	NULL
the	NULL
Bak	NULL
nor	NULL
the	NULL
p53	NULL
gene	NULL
was	NULL
expressed	NULL
by	NULL
these	NULL
cells	NULL
at	NULL
a	NULL
level	NULL
detectable	NULL
by	NULL
Northern	NULL
blot	NULL
.	NULL

The	NULL
BCL2	NULL
and	NULL
BCL-XL	NULL
proteins	NULL
were	NULL
also	NULL
==	NULL
]	NULL
A	NULL
100	NULL
f	NULL
4a	NULL
&	NULL
i	NULL
O	NULL
Medium	NULL
@	NULL
IL-6	NULL
20ng/ml	NULL
bo	NULL
&	NULL
1	NULL
Relative	NULL
Cell	NULL
Number	NULL
Viability	NULL
(	NULL
%	NULL
)	NULL
3	NULL
__	NULL
S	NULL
&	NULL
o	NULL
4	NULL
1	NULL
2	NULL
3	NULL
Culture	NULL
(	NULL
Days	NULL
)	NULL
1349	NULL
evaluated	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
5B	NULL
,	NULL
1	NULL
A9-M	NULL
cells	NULL
lost	NULL
BCL2	NULL
protein	NULL
within	NULL
36	NULL
hours	NULL
of	NULL
stimulation	NULL
with	NULL
IL-6	NULL
.	NULL

Although	NULL
expression	NULL
of	NULL
BCL-XL	NULL
mRNA	NULL
was	NULL
induced	NULL
by	NULL
IL-6	NULL
treatment	NULL
,	NULL
the	NULL
protein	NULL
was	NULL
undetectable	NULL
even	NULL
when	NULL
1	NULL
A9-M	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IL-6	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
BCL2	NULL
suppressed	NULL
IL-6-induced	NULL
apoptosis	NULL
but	NULL
not	NULL
macrophage-differentiation	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

Because	NULL
IL-6	NULL
downregulated	NULL
gene	NULL
expression	NULL
of	NULL
BCL2	NULL
,	NULL
an	NULL
antiapoptotic	NULL
gene	NULL
,	NULL
we	NULL
evaluated	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
change	NULL
for	NULL
IL-6-induced	NULL
responses	NULL
.	NULL

A	NULL
human	NULL
BCL2-expression	NULL
plas-mid	NULL
,	NULL
pSVBT	NULL
,	NULL
was	NULL
stably	NULL
transfected	NULL
into	NULL
1Â¥A9-M	NULL
cells	NULL
,	NULL
and	NULL
3	NULL
individual	NULL
clones	NULL
that	NULL
expressed	NULL
human	NULL
BCL2	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
SV40	NULL
promoter	NULL
(	NULL
1	NULL
A9-M/BCL2	NULL
)	NULL
were	NULL
obtained	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
gene	NULL
and	NULL
protein	NULL
expression	NULL
of	NULL
endogenous	NULL
and	NULL
exogenous	NULL
BCL2	NULL
of	NULL
1A9-M/BCL2	NULL
clones	NULL
was	NULL
confirmed	NULL
by	NULL
Northern	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
6A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The1A9-M/BCL2	NULL
clones	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
for	NULL
48	NULL
hours	NULL
,	NULL
and	NULL
neither	NULL
loss	NULL
of	NULL
viability	NULL
nor	NULL
apoptotic	NULL
changes	NULL
were	NULL
observed	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
1	NULL
A9-M/BCL2	NULL
clones	NULL
did	NULL
acquire	NULL
the	NULL
macrophage-like	NULL
morphology	NULL
,	NULL
along	NULL
with	NULL
CD32/CD16	NULL
and	NULL
F4/80	NULL
antigens	NULL
after	NULL
treatment	NULL
with	NULL
IL-6	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
programmed	NULL
cell	NULL
death	NULL
is	NULL
not	NULL
coupled	NULL
to	NULL
differentiation	NULL
in	NULL
the	NULL
1A9-M	NULL
cell	NULL
line	NULL
and	NULL
BCL2	NULL
is	NULL
sufficient	NULL
to	NULL
block	NULL
IL-6-induced	NULL
apoptosis	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
dominant-negative	NULL
Stat3	NULL
blocked	NULL
both	NULL
IL-6-induced	NULL
apoptosis	NULL
and	NULL
macrophage-differentiation	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

IL-6	NULL
activates	NULL
the	NULL
JAK-STAT	NULL
signal	NULL
transduction	NULL
path-way	NULL
.	NULL
'	NULL

''	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
,	NULL
but	NULL
not	NULL
Stat1	NULL
or	NULL
Stat5	NULL
,	NULL
a	NULL
Co	NULL
_	NULL
$	NULL
fas	NULL
0	NULL
hours	NULL
=	NULL
Lo	NULL
G	NULL
w	NULL
o	NULL
&	NULL
a	NULL
A	NULL
a	NULL
IL-6-Treatment	NULL
|	NULL
s	NULL
w	NULL
3	NULL
a	NULL
T	NULL
n	NULL
g	NULL
50	NULL
B3	NULL
8	NULL
ao	NULL
lg	NULL
Â§	NULL
4	NULL
&	NULL
Â£	NULL
24	NULL
hours	NULL
voM	NULL
a	NULL
4	NULL
s	NULL
Â»	NULL
-	NULL
n	NULL
<	NULL
*	NULL
%	NULL
o	NULL
@	NULL
w	NULL
m	NULL
48	NULL
hours	NULL
72	NULL
hours	NULL
Nuclear	NULL
Content	NULL
Fig	NULL
4	NULL
.	NULL

IL-6-induced	NULL
apoptosis	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

1A9-M	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
20	NULL
ng/mL	NULL
of	NULL
IL-6	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
(	NULL
A	NULL
)	NULL
cell	NULL
viability	NULL
,	NULL
(	NULL
B	NULL
)	NULL
nuclear	NULL
DNA	NULL
content	NULL
,	NULL
and	NULL
(	NULL
C	NULL
)	NULL
DNA	NULL
fragmentation	NULL
analysis	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Each	NULL
figure	NULL
show	NULL
s	NULL
one	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1350	NULL
IL-6	NULL
Treatment	NULL
(	NULL
hours	NULL
)	NULL
0	NULL
12	NULL
24	NULL
36	NULL
48	NULL
60	NULL
B	NULL
IL-6	NULL
Treatment	NULL
(	NULL
hours	NULL
)	NULL
0	NULL
24	NULL
36	NULL
BCL2	NULL
'*	NULL
#	NULL
Fig	NULL
5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Expression	NULL
of	NULL
apoptosis-related	NULL
genes	NULL
during	NULL
culture	NULL
with	NULL
IL-6	NULL
.	NULL

1A9-M	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
20	NULL
ng/mL	NULL
of	NULL
IL-6	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
the	NULL
cDNAs	NULL
of	NULL
BCL2	NULL
,	NULL
BCL-XL	NULL
,	NULL
Bax	NULL
,	NULL
Bak	NULL
,	NULL
p53	NULL
,	NULL
and	NULL
B-actin	NULL
as	NULL
probes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
BCL2	NULL
protein	NULL
during	NULL
culture	NULL
with	NULL
IL-6	NULL
.	NULL

1A9-M	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
20	NULL
ng/mL	NULL
of	NULL
IL-6	NULL
for	NULL
the	NULL
indicated	NULL
periods	NULL
.	NULL

Whole	NULL
cellular	NULL
lysates	NULL
were	NULL
obtained	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
antimouse	NULL
BCL2	NULL
antibody	NULL
.	NULL

was	NULL
observed	NULL
when	NULL
1A9-M	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-6	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
importance	NULL
of	NULL
Stat3-mediated	NULL
signals	NULL
to	NULL
IL-6-induced	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
,	NULL
we	NULL
stably	NULL
transfected	NULL
a	NULL
pCAGGS-Neo-HA-Stat3D	NULL
plasmid	NULL
into	NULL
1A9-M	NULL
cells	NULL
.	NULL

Twenty	NULL
individual	NULL
clones	NULL
were	NULL
obtained	NULL
that	NULL
expressed	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
Stat3	NULL
carrying	NULL
mutations	NULL
at	NULL
positions	NULL
important	NULL
for	NULL
DNA	NULL
binding	NULL
(	NULL
1A9-M/ST3D	NULL
)	NULL
.	NULL

All	NULL
1A9-M/ST3D	NULL
clones	NULL
showed	NULL
diminished	NULL
levels	NULL
of	NULL
IL-6-activated	NULL
transcription	NULL
from	NULL
the	NULL
4X	NULL
APRE	NULL
reporter	NULL
plasmid	NULL
that	NULL
contains	NULL
a	NULL
potential	NULL
Stat3-binding	NULL
sequence	NULL
(	NULL
Fig	NULL
6C	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
then	NULL
examined	NULL
biological	NULL
responses	NULL
of	NULL
the	NULL
1A9-M/ST3D	NULL
clones	NULL
to	NULL
IL-6	NULL
.	NULL

Neither	NULL
macrophage-differentiation	NULL
nor	NULL
apoptosis	NULL
was	NULL
induced	NULL
by	NULL
IL-6	NULL
when	NULL
Stat3	NULL
functions	NULL
were	NULL
disrupted	NULL
.	NULL

Eighteen	NULL
of	NULL
20	NULL
1A9-M/ST3D	NULL
clones	NULL
(	NULL
clone	NULL
1-18	NULL
)	NULL
did	NULL
not	NULL
undergo	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
IL-6	NULL
(	NULL
Table	NULL
2	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

They	NULL
also	NULL
exhibit	NULL
neither	NULL
morphological	NULL
changes	NULL
nor	NULL
acquisition	NULL
of	NULL
macrophage	NULL
antigens	NULL
in	NULL
response	NULL
to	NULL
IL-6	NULL
(	NULL
Table	NULL
3	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Stat3	NULL
was	NULL
likely	NULL
to	NULL
mediate	NULL
signals	NULL
for	NULL
IL-6-induced	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
of	NULL
1A9-M	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
other	NULL
two	NULL
clones	NULL
(	NULL
1A9-M/ST3D	NULL
clones	NULL
A	NULL
ORITANI	NULL
ET	NULL
AL	NULL
1s	NULL
toll	NULL
#	NULL
#	NULL
#	NULL
B	NULL
-aEndogenous	NULL
BCL2	NULL
@	NULL
Exogenous	NULL
B	NULL
-actin	NULL
ï¬	NULL
ih	NULL
Sk	NULL
tA	NULL
Mouse	NULL
BCL2	NULL
Human	NULL
BCL2	NULL
|	NULL
}	NULL
C	NULL
ta	NULL
]	NULL
Medium	NULL
RN	NULL
IL-6	NULL
20ng/mL	NULL
hea	NULL
D	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
0	NULL
0Â°	NULL
â	NULL
ON	NULL
(	NULL
Â«	NULL
W	NULL
ï¬rv	NULL
5	NULL
J	NULL
8	NULL
8	NULL
A	NULL
o	NULL
C	NULL
4	NULL
4	NULL
Â£	NULL
#	NULL
g	NULL
4	NULL
4	NULL
S	NULL
$	NULL
Â«	NULL
z	NULL
_	NULL
,	NULL
y	NULL
_	NULL
,	NULL
Fig	NULL
6	NULL
.	NULL

Expression	NULL
of	NULL
BCL2	NULL
gene	NULL
in	NULL
1A9-M/BCL2	NULL
clones	NULL
and	NULL
effects	NULL
of	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
Stat3	NULL
in	NULL
1A9-M/ST3D	NULL
clones	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Total	NULL
RNAs	NULL
from	NULL
parent	NULL
1A9-M	NULL
or	NULL
1A9-M/BCL2	NULL
clones	NULL
were	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
the	NULL
cDNAs	NULL
of	NULL
BCL2	NULL
and	NULL
B-actin	NULL
as	NULL
probes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Whole	NULL
cellular	NULL
lysates	NULL
were	NULL
obtained	NULL
from	NULL
parent	NULL
1A9-M	NULL
or	NULL
1A9-M/BCL2	NULL
clones	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
antimouse	NULL
BCL2	NULL
or	NULL
antihuman	NULL
BCL2	NULL
antibody	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Parent	NULL
1A9-M	NULL
cells	NULL
and	NULL
1A9-M/ST3D	NULL
(	NULL
clone	NULL
1	NULL
,	NULL
2	NULL
,	NULL
A	NULL
,	NULL
B	NULL
)	NULL
were	NULL
electroporated	NULL
with	NULL
30	NULL
pg	NULL
of	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
4x	NULL
APRE	NULL
together	NULL
with	NULL
30	NULL
pg	NULL
of	NULL
pRL-CMV-Rluc	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
serum-starved	NULL
for	NULL
12	NULL
hours	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
20	NULL
ng/	NULL
mL	NULL
IL-6	NULL
for	NULL
5	NULL
hours	NULL
.	NULL

The	NULL
relative	NULL
firefly	NULL
luciferase	NULL
activities	NULL
were	NULL
calculated	NULL
by	NULL
normalizing	NULL
transfection	NULL
efficiency	NULL
according	NULL
to	NULL
the	NULL
renilla	NULL
luciferase	NULL
activities	NULL
.	NULL

The	NULL
results	NULL
are	NULL
show	NULL
n	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicated	NULL
experiments	NULL
.	NULL

(	NULL
C	NULL
)	NULL
)	NULL
Unstimu-lated	NULL
;	NULL
(	NULL
MI	NULL
)	NULL
20	NULL
ng/	NULL
mL	NULL
IL-6	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MACROPHAGE	NULL
DIFFERENTIATION	NULL
AND	NULL
APOPTOSIS	NULL
Table	NULL
2	NULL
.	NULL

Inhibition	NULL
of	NULL
IL-6-Induced	NULL
Apoptosis	NULL
of	NULL
1A9-M	NULL
Cells	NULL
by	NULL
a	NULL
Dominant-Negative	NULL
Form	NULL
of	NULL
Stat3	NULL
and	NULL
by	NULL
Constitutively	NULL
Expressed	NULL
BCL2	NULL
Increase	NULL
of	NULL
Loss	NULL
of	NULL
Transfectant	NULL
Subdiploid	NULL
(	NULL
%	NULL
)	NULL
Viability	NULL
(	NULL
%	NULL
)	NULL
Parent	NULL
1A9-M	NULL
32.4	NULL
+	NULL
1.52	NULL
33.0	NULL
+	NULL
3.40	NULL
1A9-M/pCAGGS	NULL
clone	NULL
1	NULL
30.7	NULL
+	NULL
1.77	NULL
39.7	NULL
+	NULL
5.35	NULL
1A9-M/pCAGGS	NULL
clone	NULL
2	NULL
32.4	NULL
+	NULL
1.71	NULL
41.3	NULL
+	NULL
3.68	NULL
1A9-M/pCAGGS	NULL
clone	NULL
3	NULL
29.9	NULL
+	NULL
2.32	NULL
38.4	NULL
+	NULL
3.69	NULL
1A9-M/ST3D	NULL
clone	NULL
1	NULL
0.8	NULL
+	NULL
0.29	NULL
3.7	NULL
#	NULL
1.41	NULL
1A9-M/ST3D	NULL
clone	NULL
2	NULL
0.7	NULL
+	NULL
0.25	NULL
3.3	NULL
+	NULL
0.94	NULL
1A9-M/ST3D	NULL
clone	NULL
A	NULL
4.9	NULL
+	NULL
1.22	NULL
7.7	NULL
#	NULL
1.25	NULL
1A9-M/ST3D	NULL
clone	NULL
B	NULL
33.5	NULL
+	NULL
1.57	NULL
42.4	NULL
+	NULL
2.87	NULL
1A9-M/BCL2	NULL
clone	NULL
1	NULL
0.2	NULL
+	NULL
0.29	NULL
3.0	NULL
+	NULL
1.41	NULL
1A9-M/BCL2	NULL
clone	NULL
2	NULL
1.3	NULL
+	NULL
0.43	NULL
44	NULL
+	NULL
1.25	NULL
1A9-M/BCL2	NULL
clone	NULL
3	NULL
3.3	NULL
+	NULL
0.71	NULL
7.7	NULL
+	NULL
2.05	NULL
1A9-M/pCAGGS	NULL
(	NULL
clone	NULL
1-3	NULL
)	NULL
,	NULL
1A9-M/ST3D	NULL
(	NULL
clone	NULL
1	NULL
,	NULL
2	NULL
,	NULL
A	NULL
,	NULL
B	NULL
)	NULL
,	NULL
1A9-M/	NULL
BCL2	NULL
(	NULL
clone	NULL
1-3	NULL
)	NULL
,	NULL
and	NULL
parent	NULL
1A9-M	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
20	NULL
ng/mL	NULL
IL-6	NULL
for	NULL
48	NULL
hours	NULL
.	NULL

Nuclear	NULL
DNA	NULL
content	NULL
was	NULL
analyzed	NULL
with	NULL
FACSort	NULL
using	NULL
Cell	NULL
Quest	NULL
software	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
.	NULL

The	NULL
increase	NULL
of	NULL
subdiploid	NULL
or	NULL
dead	NULL
cell	NULL
populations	NULL
by	NULL
IL-6	NULL
treatment	NULL
is	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
cultures	NULL
.	NULL

and	NULL
B	NULL
)	NULL
showed	NULL
unexpected	NULL
responses	NULL
to	NULL
IL-6	NULL
(	NULL
Tables	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

One	NULL
clone	NULL
(	NULL
1A9-M/ST3D	NULL
clone	NULL
A	NULL
)	NULL
had	NULL
slight	NULL
macrophage	NULL
differentiation	NULL
,	NULL
although	NULL
its	NULL
viability	NULL
was	NULL
retained	NULL
.	NULL

Approximately	NULL
30	NULL
%	NULL
of	NULL
cells	NULL
became	NULL
apoptotic	NULL
in	NULL
another	NULL
stable	NULL
clone	NULL
(	NULL
1A9-M/ST3D	NULL
clone	NULL
B	NULL
)	NULL
,	NULL
without	NULL
differentiation	NULL
into	NULL
macrophages	NULL
.	NULL

Stat3	NULL
was	NULL
not	NULL
involved	NULL
in	NULL
downregulation	NULL
of	NULL
BCL2	NULL
gene	NULL
expression	NULL
by	NULL
IL-6	NULL
.	NULL

Experiments	NULL
described	NULL
above	NULL
indicated	NULL
that	NULL
BCL2	NULL
might	NULL
be	NULL
a	NULL
critical	NULL
determinant	NULL
for	NULL
life/death	NULL
decisions	NULL
in	NULL
1A9-M	NULL
cells	NULL
that	NULL
are	NULL
exposed	NULL
to	NULL
IL-6	NULL
.	NULL

It	NULL
seemed	NULL
possible	NULL
that	NULL
the	NULL
IL-6-induced	NULL
downregulation	NULL
of	NULL
BCL2	NULL
gene	NULL
expression	NULL
might	NULL
be	NULL
dependent	NULL
on	NULL
Stat3	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
evalu-	NULL
Table	NULL
3	NULL
.	NULL

Inhibition	NULL
of	NULL
IL-6-Induced	NULL
Macrophage	NULL
Differentiation	NULL
of	NULL
1A9-M	NULL
Cells	NULL
by	NULL
a	NULL
Dominant-Negative	NULL
Form	NULL
of	NULL
Stat3	NULL
,	NULL
But	NULL
Not	NULL
by	NULL
Constitutively	NULL
Expressed	NULL
BCL2	NULL
Increased	NULL
Median	NULL
Auorescence	NULL
.	NULL

Morphological	NULL
--	NULL
-	NULL
__	NULL
Change	NULL
Into	NULL
Transfectant	NULL
F4/8O	NULL
CD32	NULL
Macrophages	NULL
(	NULL
%	NULL
)	NULL
Parent	NULL
1A9-M	NULL
34.0	NULL
+	NULL
1.87	NULL
248.1	NULL
+	NULL
11.98	NULL
-	NULL
85.0	NULL
+	NULL
3.68	NULL
1A9-M/pCAGGS	NULL
clone	NULL
1	NULL
49.6	NULL
+	NULL
5.51	NULL
304.1	NULL
+	NULL
14.30	NULL
|	NULL
84.5	NULL
+	NULL
5.64	NULL
1A9-M/pCAGGS	NULL
clone	NULL
2	NULL
34.7	NULL
+	NULL
3.85	NULL
242.3	NULL
+	NULL
4.53	NULL
84.7	NULL
+	NULL
3.74	NULL
1A9-M/pCAGGS	NULL
clone	NULL
3	NULL
31.9	NULL
+	NULL
1.70	NULL
220.2	NULL
+	NULL
10.99	NULL
83.0	NULL
+	NULL
3.40	NULL
1A9-M/ST3D	NULL
clone	NULL
1	NULL
0.3	NULL
+	NULL
0.33	NULL
5.6	NULL
+	NULL
1.70	NULL
1.8	NULL
+	NULL
0.82	NULL
1A9-M/ST3D	NULL
clone	NULL
2	NULL
0.3	NULL
+	NULL
0.21	NULL
7.3	NULL
+	NULL
0.98	NULL
3.0	NULL
Â£	NULL
1.25	NULL
1A9-M/ST3D	NULL
clone	NULL
A	NULL
8.6	NULL
Â£	NULL
1.03	NULL
75.1	NULL
+	NULL
7.35	NULL
48.8	NULL
+	NULL
5.24	NULL
1A9-M/ST3D	NULL
clone	NULL
B	NULL
0.5	NULL
+	NULL
0.45	NULL
8.2	NULL
+	NULL
1.07	NULL
4.7	NULL
+	NULL
2.82	NULL
1A9-M/BCL2	NULL
clone	NULL
1	NULL
36.9	NULL
+	NULL
2.67	NULL
225.1	NULL
+	NULL
8.26	NULL
81.8	NULL
+	NULL
4.78	NULL
1A9-M/BCL2	NULL
clone	NULL
2	NULL
36.6	NULL
+	NULL
4.13	NULL
220.9	NULL
+	NULL
17.90	NULL
-	NULL
84.5	NULL
+	NULL
4.50	NULL
1A9-M/BCL2	NULL
clone	NULL
3	NULL
32.4	NULL
+	NULL
2.09	NULL
260.4	NULL
+	NULL
9.66	NULL
88.8	NULL
+	NULL
3.74	NULL
1A9-M/pCAGGS	NULL
(	NULL
clone	NULL
1-3	NULL
)	NULL
,	NULL
1A9-M/ST3D	NULL
(	NULL
clone	NULL
1	NULL
,	NULL
2	NULL
,	NULL
A	NULL
,	NULL
B	NULL
)	NULL
,	NULL
1A9-M/	NULL
BCL2	NULL
(	NULL
clone	NULL
1-3	NULL
)	NULL
,	NULL
and	NULL
parent	NULL
1A9-M	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
20	NULL
ng/mL	NULL
IL-6	NULL
for	NULL
48	NULL
hours	NULL
.	NULL

Surface	NULL
expression	NULL
of	NULL
CD32/CD16	NULL
and	NULL
a	NULL
F4/80	NULL
antigen	NULL
was	NULL
evaluated	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

To	NULL
determine	NULL
morphological	NULL
changes	NULL
into	NULL
macrophages	NULL
,	NULL
cultured	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
May-Grunwald	NULL
Giemsa	NULL
.	NULL

The	NULL
increase	NULL
of	NULL
cells	NULL
expressing	NULL
F4/80	NULL
antigen	NULL
or	NULL
CD32	NULL
and	NULL
morphologically	NULL
macrophage-like	NULL
cells	NULL
by	NULL
IL-6	NULL
treatment	NULL
is	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
cultures	NULL
.	NULL

1351	NULL
ated	NULL
BCL2	NULL
transcripts	NULL
in	NULL
the	NULL
1A9-M/ST3D	NULL
clones	NULL
before	NULL
and	NULL
after	NULL
stimulation	NULL
with	NULL
IL-6	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
7	NULL
,	NULL
IL-6	NULL
downregulated	NULL
BCL2	NULL
gene	NULL
expression	NULL
within	NULL
24	NULL
hours	NULL
in	NULL
all	NULL
of	NULL
the	NULL
1A9-M/ST3D	NULL
clones	NULL
to	NULL
an	NULL
equivalent	NULL
degree	NULL
as	NULL
in	NULL
the	NULL
control	NULL
.	NULL

DISCUSSION	NULL
BMS2.4	NULL
stromal	NULL
cells	NULL
probably	NULL
produce	NULL
multiple	NULL
factors	NULL
that	NULL
modulate	NULL
the	NULL
survival	NULL
and	NULL
growth	NULL
of	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Their	NULL
identification	NULL
may	NULL
be	NULL
helpful	NULL
in	NULL
understanding	NULL
cytokines	NULL
that	NULL
limit	NULL
blood	NULL
cell	NULL
production	NULL
under	NULL
steady	NULL
state	NULL
or	NULL
conditions	NULL
associated	NULL
with	NULL
unusual	NULL
demands	NULL
.	NULL

We	NULL
used	NULL
the	NULL
particularly	NULL
sensitive	NULL
1A9-M	NULL
,	NULL
a	NULL
pre-B-cell	NULL
line	NULL
,	NULL
and	NULL
expression	NULL
cloning	NULL
to	NULL
determine	NULL
that	NULL
IL-6	NULL
is	NULL
one	NULL
of	NULL
the	NULL
active	NULL
substances	NULL
produced	NULL
by	NULL
BMS2.4	NULL
.	NULL

The	NULL
1A9-M	NULL
cells	NULL
underwent	NULL
remarkable	NULL
changes	NULL
in	NULL
morphology	NULL
,	NULL
expressed	NULL
macrophage	NULL
surface	NULL
markers	NULL
,	NULL
and	NULL
then	NULL
underwent	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
IL-6	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
these	NULL
dramatic	NULL
responses	NULL
are	NULL
dependent	NULL
on	NULL
specific	NULL
components	NULL
of	NULL
the	NULL
JAK-STAT	NULL
pathway	NULL
and	NULL
that	NULL
independent	NULL
signaling	NULL
mechanisms	NULL
account	NULL
for	NULL
downregulation	NULL
of	NULL
BCL2	NULL
expression	NULL
.	NULL

Lymphocyte	NULL
lines	NULL
and	NULL
normal	NULL
IL-7-responding	NULL
cells	NULL
were	NULL
unaffected	NULL
by	NULL
IL-6	NULL
,	NULL
but	NULL
inhibited	NULL
by	NULL
BMS2.4	NULL
supernatant	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
BMS2.4	NULL
line	NULL
must	NULL
make	NULL
other	NULL
negative	NULL
lympho-poietic	NULL
regulators	NULL
that	NULL
can	NULL
be	NULL
investigated	NULL
using	NULL
a	NULL
similar	NULL
experimental	NULL
strategy	NULL
.	NULL

The	NULL
1A9-M	NULL
cell	NULL
line	NULL
was	NULL
chosen	NULL
for	NULL
screening	NULL
an	NULL
expression	NULL
library	NULL
because	NULL
of	NULL
its	NULL
sensitivity	NULL
to	NULL
BMS2.4	NULL
supernatant	NULL
inhibition	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
also	NULL
remarkable	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
undergo	NULL
an	NULL
apparent	NULL
lineage	NULL
switch	NULL
before	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

There	NULL
have	NULL
been	NULL
several	NULL
previous	NULL
m=	NULL
Â©	NULL
&	NULL
L	NULL
E	NULL
E	NULL
--	NULL
ea	NULL
&	NULL
a	NULL
)	NULL
2	NULL
&	NULL
w	NULL
w	NULL
2	NULL
2	NULL
<	NULL
A	NULL
=	NULL
A	NULL
W	NULL
(	NULL
@	NULL
ba	NULL
E	NULL
[	NULL
=	NULL
``	NULL
E-	NULL
_	NULL
_	NULL
<	NULL
E	NULL
=	NULL
=	NULL
o	NULL
o	NULL
a	NULL
&	NULL
<	NULL
0	NULL
%	NULL
<	NULL
Â©	NULL
IL-6-	NULL
T	NULL
~	NULL
H	NULL
T	NULL
Y	NULL
t	NULL
j	NULL
Treatment	NULL
BCL2	NULL
i	NULL
4	NULL
â	NULL
a	NULL
-28S	NULL
Ã©	NULL
f	NULL
-188	NULL
f	NULL
-actin	NULL
â	NULL
Q	NULL
p	NULL
Fig	NULL
7	NULL
.	NULL

A	NULL
dominant-negative	NULL
form	NULL
of	NULL
Stat3	NULL
did	NULL
not	NULL
inhibit	NULL
IL-6-induced	NULL
repression	NULL
of	NULL
BCL2	NULL
mRNA	NULL
expression	NULL
.	NULL

1A9-M	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
a	NULL
control	NULL
vector	NULL
(	NULL
1A9-M/pCAGGS	NULL
clone	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
a	NULL
pCAGGS-Neo-HA-Stat3D	NULL
plasmid	NULL
(	NULL
1A9-M/ST3D	NULL
clone	NULL
1	NULL
and	NULL
2	NULL
)	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
20	NULL
ng/mL	NULL
IL-6	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
cDNAs	NULL
of	NULL
BCL2	NULL
and	NULL
B-actin	NULL
as	NULL
probes	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1352	NULL
examples	NULL
of	NULL
pre-B	NULL
cells	NULL
that	NULL
have	NULL
undergone	NULL
a	NULL
macrophage-like	NULL
change	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
the	NULL
change	NULL
was	NULL
spontaneous	NULL
(	NULL
HATFL	NULL
and	NULL
70Z/3	NULL
)	NULL
,	NULL
in	NULL
others	NULL
it	NULL
was	NULL
induced	NULL
by	NULL
a	NULL
proto-oncogene	NULL
or	NULL
ectopic	NULL
expression	NULL
of	NULL
the	NULL
c-fms	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
.	NULL
``	NULL

This	NULL
may	NULL
indicate	NULL
that	NULL
commitment	NULL
between	NULL
these	NULL
two	NULL
cell	NULL
lineages	NULL
involves	NULL
relatively	NULL
few	NULL
transcription	NULL
factors	NULL
.	NULL

Regardless	NULL
,	NULL
we	NULL
are	NULL
unaware	NULL
of	NULL
another	NULL
cell	NULL
line	NULL
that	NULL
undergoes	NULL
this	NULL
change	NULL
before	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Whereas	NULL
two	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
M1	NULL
and	NULL
Y6	NULL
,	NULL
were	NULL
previously	NULL
found	NULL
to	NULL
undergo	NULL
macrophage-differentiation	NULL
in	NULL
response	NULL
to	NULL
IL-6	NULL
,	NULL
1	NULL
A9-M	NULL
cells	NULL
may	NULL
provide	NULL
a	NULL
unique	NULL
model	NULL
for	NULL
exploring	NULL
IL-6-dependent	NULL
mechanisms	NULL
.	NULL

Stat	NULL
family	NULL
members	NULL
were	NULL
originally	NULL
identified	NULL
as	NULL
transcription	NULL
factors	NULL
responsible	NULL
for	NULL
interferon-w-	NULL
and	NULL
interferon-y-dependent	NULL
gene	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
All	NULL
Stat	NULL
molecules	NULL
have	NULL
an	NULL
SH2	NULL
domain	NULL
,	NULL
which	NULL
recognizes	NULL
phosphotyrosine	NULL
in	NULL
a	NULL
specific	NULL
peptide	NULL
motif	NULL
,	NULL
and	NULL
are	NULL
generally	NULL
involved	NULL
in	NULL
cytokine	NULL
signal	NULL
transduc-tion	NULL
.	NULL

'*	NULL
``	NULL
For	NULL
examples	NULL
,	NULL
Stat1	NULL
is	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
innate	NULL
immunity	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Statd4	NULL
is	NULL
activated	NULL
by	NULL
IL-12	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
development	NULL
of	NULL
natural	NULL
killer	NULL
and	NULL
T-helper	NULL
type	NULL
1	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Stat6	NULL
is	NULL
involved	NULL
in	NULL
Ig	NULL
E	NULL
production	NULL
and	NULL
lymphocyte	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
.	NULL
``	NULL

The	NULL
JAK-STAT	NULL
pathway	NULL
also	NULL
mediates	NULL
signal	NULL
transduction	NULL
through	NULL
the	NULL
IL-6	NULL
receptor	NULL
subunit	NULL
,	NULL
gp130	NULL
.	NULL

JAK1	NULL
,	NULL
JAK2	NULL
,	NULL
and	NULL
Tyk2	NULL
constitutively	NULL
associate	NULL
with	NULL
gp130	NULL
and	NULL
respond	NULL
to	NULL
IL-6.4Â°	NULL
These	NULL
activated	NULL
tyrosine	NULL
kinases	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
phosphorylate	NULL
and	NULL
activate	NULL
the	NULL
Stat	NULL
family	NULL
proteins	NULL
,	NULL
especially	NULL
Statl	NULL
and	NULL
Stat3	NULL
for	NULL
IL-6.4'42	NULL
Recently	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
gp130	NULL
mutants	NULL
without	NULL
any	NULL
of	NULL
YXXQ	NULL
motifs	NULL
required	NULL
for	NULL
Stat3	NULL
activation	NULL
did	NULL
not	NULL
activate	NULL
Stat3	NULL
or	NULL
induce	NULL
terminal	NULL
differentiation	NULL
of	NULL
M1	NULL
cells	NULL
.	NULL
``	NULL

Moreover	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
dominant-negative	NULL
forms	NULL
of	NULL
Stat3	NULL
inhibited	NULL
IL-6-induced	NULL
macrophage-differentiation	NULL
of	NULL
M1	NULL
transformants	NULL
.	NULL

?	NULL

Although	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
Stat3	NULL
may	NULL
be	NULL
important	NULL
for	NULL
IL-6-induced	NULL
macro-phage-differentiation	NULL
,	NULL
all	NULL
of	NULL
the	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
M1	NULL
cell	NULL
line	NULL
.	NULL

We	NULL
now	NULL
report	NULL
similar	NULL
observations	NULL
with	NULL
1A9-M	NULL
cells	NULL
and	NULL
can	NULL
conclude	NULL
that	NULL
the	NULL
phenomena	NULL
may	NULL
be	NULL
general	NULL
.	NULL

Apoptosis	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
physiological	NULL
processes	NULL
,	NULL
including	NULL
removal	NULL
of	NULL
redundant	NULL
cells	NULL
during	NULL
development	NULL
,	NULL
elimination	NULL
of	NULL
autoreactive	NULL
lymphocytes	NULL
,	NULL
and	NULL
eradication	NULL
of	NULL
old	NULL
and	NULL
differentiated	NULL
cells	NULL
in	NULL
most	NULL
adult	NULL
tissues	NULL
with	NULL
self-renewal	NULL
capacity	NULL
.	NULL
``	NULL

''	NULL
Apoptosis	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
has	NULL
emerged	NULL
as	NULL
a	NULL
central	NULL
regulatory	NULL
event	NULL
in	NULL
hematopoiesis	NULL
and	NULL
inflammation	NULL
,	NULL
and	NULL
inflammatory	NULL
cytokines	NULL
can	NULL
promote	NULL
or	NULL
prevent	NULL
their	NULL
apoptosis	NULL
.	NULL
``	NULL

A	NULL
number	NULL
of	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
Bax	NULL
,	NULL
Bak	NULL
,	NULL
p53	NULL
,	NULL
BCL2	NULL
,	NULL
and	NULL
BCL-XL	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
control	NULL
apoptosis	NULL
of	NULL
cells	NULL
and	NULL
to	NULL
alter	NULL
their	NULL
gene	NULL
expression	NULL
during	NULL
differentiation	NULL
.	NULL
``	NULL

In	NULL
1A9-M	NULL
cells	NULL
,	NULL
IL-6	NULL
induced	NULL
both	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
.	NULL

Expression	NULL
of	NULL
p53	NULL
and	NULL
Bak	NULL
genes	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
1A9-M	NULL
cells	NULL
,	NULL
and	NULL
BCL-XL	NULL
was	NULL
induced	NULL
by	NULL
IL-6	NULL
treatment	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
BCL2	NULL
was	NULL
downregulated	NULL
by	NULL
IL-6	NULL
treatment	NULL
.	NULL

Because	NULL
BCL2	NULL
is	NULL
an	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
,	NULL
downregulation	NULL
of	NULL
BCL2	NULL
may	NULL
be	NULL
related	NULL
to	NULL
IL-6-induced	NULL
apoptosis	NULL
of	NULL
1	NULL
A9-M	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
downregulation	NULL
of	NULL
gene	NULL
and	NULL
protein	NULL
expression	NULL
of	NULL
BCL2	NULL
may	NULL
be	NULL
important	NULL
for	NULL
apoptosis	NULL
,	NULL
because	NULL
constitutively	NULL
expressed	NULL
BCL2	NULL
blocked	NULL
IL-6-induced	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

The	NULL
cAMP	NULL
response-binding	NULL
proteins	NULL
,	NULL
p53	NULL
,	NULL
and	NULL
c-myb	NULL
are	NULL
known	NULL
to	NULL
regulate	NULL
BCL2	NULL
gene	NULL
expression	NULL
positively	NULL
or	NULL
negatively	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cells	NULL
.	NULL

``	NULL
?	NULL

52	NULL
ORITANI	NULL
ET	NULL
AL	NULL
In	NULL
a	NULL
pro-B-cell	NULL
line	NULL
,	NULL
the	NULL
tyrosine	NULL
residue	NULL
in	NULL
the	NULL
YXXQ	NULL
motifs	NULL
of	NULL
gp130	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
Stat3	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
BCL2	NULL
induction	NULL
and	NULL
antiapoptotic	NULL
effects	NULL
.	NULL
``	NULL

''	NULL
However	NULL
,	NULL
in	NULL
1	NULL
A9-M	NULL
cells	NULL
,	NULL
Stat3	NULL
was	NULL
not	NULL
related	NULL
to	NULL
regulation	NULL
of	NULL
BCL2	NULL
,	NULL
because	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
Stat3	NULL
did	NULL
not	NULL
block	NULL
IL-6-induced	NULL
downregulation	NULL
of	NULL
BCL2	NULL
expression	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
a	NULL
Stat3-dependent	NULL
pathway	NULL
is	NULL
also	NULL
required	NULL
for	NULL
IL-6-induced	NULL
apoptosis	NULL
of	NULL
1	NULL
A9-M	NULL
cells	NULL
,	NULL
because	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
Stat3	NULL
maintained	NULL
their	NULL
viability	NULL
.	NULL

We	NULL
could	NULL
speculate	NULL
that	NULL
there	NULL
is	NULL
induction	NULL
of	NULL
apoptosis-related	NULL
genes	NULL
other	NULL
than	NULL
p53	NULL
,	NULL
Bak	NULL
,	NULL
and	NULL
Bax	NULL
or	NULL
reduction	NULL
of	NULL
some	NULL
antiapoptotic	NULL
genes	NULL
beside	NULL
BCL2	NULL
and	NULL
BCL-XL	NULL
.	NULL

In	NULL
M1	NULL
cells	NULL
,	NULL
Stat3	NULL
is	NULL
involved	NULL
in	NULL
IL-6-induction	NULL
of	NULL
several	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
the	NULL
junB	NULL
,	NULL
interferon	NULL
regulatory	NULL
factor-1	NULL
,	NULL
a	NULL
CDK	NULL
inhibitor	NULL
p19N**	NULL
``	NULL
,	NULL
and	NULL
Stat3	NULL
itself	NULL
,	NULL
and	NULL
in	NULL
repression	NULL
of	NULL
c-myb	NULL
and	NULL
c-myc	NULL
that	NULL
may	NULL
regulate	NULL
macrophage-differentiation	NULL
and	NULL
G1	NULL
growth	NULL
arrest	NULL
.	NULL

``	NULL
``	NULL
*~	NULL
``	NULL
``	NULL
It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
analyze	NULL
molecular	NULL
mechanisms	NULL
through	NULL
which	NULL
the	NULL
Stat3-dependent	NULL
signalings	NULL
induce	NULL
apoptosis	NULL
in	NULL
1	NULL
A9-M	NULL
cells	NULL
.	NULL

We	NULL
created	NULL
stable	NULL
1A9-M	NULL
transfectants	NULL
using	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
Stat3	NULL
and	NULL
found	NULL
that	NULL
they	NULL
have	NULL
three	NULL
patterns	NULL
of	NULL
response	NULL
to	NULL
IL-6	NULL
.	NULL

Eighteen	NULL
of	NULL
20	NULL
1A9-M/ST3D	NULL
did	NULL
not	NULL
differentiate	NULL
to	NULL
macrophages	NULL
or	NULL
undergo	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
IL-6	NULL
.	NULL

The	NULL
1A9-M/ST3D	NULL
clone	NULL
A	NULL
differentiated	NULL
to	NULL
macrophages	NULL
without	NULL
apoptosis	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
1A9-M/ST3D	NULL
clone	NULL
B	NULL
died	NULL
by	NULL
apoptosis	NULL
without	NULL
macrophage-differentiation	NULL
when	NULL
stimulated	NULL
.	NULL

These	NULL
three	NULL
groups	NULL
of	NULL
cells	NULL
differ	NULL
from	NULL
untransfected	NULL
1A9-M	NULL
cells	NULL
that	NULL
differentiated	NULL
to	NULL
macrophages	NULL
and	NULL
died	NULL
in	NULL
response	NULL
to	NULL
IL-6	NULL
.	NULL

Because	NULL
the	NULL
mutated	NULL
Stat3	NULL
interfered	NULL
with	NULL
DNA	NULL
binding	NULL
of	NULL
endogenous	NULL
Stat3	NULL
in	NULL
all	NULL
1A9-M/ST3D	NULL
clones	NULL
,	NULL
a	NULL
second	NULL
mutation	NULL
due	NULL
to	NULL
prolonged	NULL
selection	NULL
might	NULL
occur	NULL
in	NULL
the	NULL
exceptional	NULL
clones	NULL
(	NULL
clone	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
are	NULL
suitable	NULL
for	NULL
substrates	NULL
of	NULL
subtraction	NULL
techniques	NULL
,	NULL
and	NULL
further	NULL
analysis	NULL
may	NULL
show	NULL
the	NULL
molecular	NULL
mechanisms	NULL
through	NULL
which	NULL
IL-6	NULL
induces	NULL
macrophage-differentiation	NULL
and	NULL
apoptosis	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Long	NULL
MW	NULL
:	NULL
Blood	NULL
cell	NULL
cytoadhesion	NULL
molecules	NULL
.	NULL

Exp	NULL
Hematol	NULL
20:288	NULL
,	NULL
1992	NULL
2	NULL
.	NULL

Kincade	NULL
PW	NULL
:	NULL
Cell	NULL
adhesion	NULL
mechanisms	NULL
utilized	NULL
for	NULL
lymphohemo-poiesis	NULL
,	NULL
in	NULL
Shimizu	NULL
Y	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Lymphocyte	NULL
Adhesion	NULL
Molecules	NULL
.	NULL

Austin	NULL
,	NULL
TX	NULL
,	NULL
Landes	NULL
,	NULL
1993	NULL
,	NULL
p	NULL
249	NULL
3	NULL
.	NULL

Verfaillie	NULL
C	NULL
,	NULL
Hurley	NULL
R	NULL
,	NULL
Bhatia	NULL
R	NULL
,	NULL
McCarthy	NULL
JB	NULL
:	NULL
Role	NULL
of	NULL
bone	NULL
marrow	NULL
matrix	NULL
in	NULL
normal	NULL
and	NULL
abnormal	NULL
hematopoiesis	NULL
.	NULL

Crit	NULL
Rev	NULL
Oncol	NULL
Hematol	NULL
16:201	NULL
,	NULL
1994	NULL
4	NULL
.	NULL

Miyake	NULL
K	NULL
,	NULL
Medina	NULL
K	NULL
,	NULL
Ishihara	NULL
K	NULL
,	NULL
Kimoto	NULL
M	NULL
,	NULL
Auerbach	NULL
R	NULL
,	NULL
Kincade	NULL
PW	NULL
:	NULL
A	NULL
VCAM-like	NULL
adhesion	NULL
molecule	NULL
on	NULL
murine	NULL
bone	NULL
marrow	NULL
stromal	NULL
cells	NULL
mediates	NULL
binding	NULL
of	NULL
lymphocyte	NULL
precursors	NULL
in	NULL
culture	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
114:557	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Miyake	NULL
K	NULL
,	NULL
Weissman	NULL
IL	NULL
,	NULL
Greengerger	NULL
JS	NULL
,	NULL
Kincade	NULL
PW	NULL
:	NULL
Evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
the	NULL
integrin	NULL
VLA-4	NULL
in	NULL
lympho-hemopoiesis	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
173:599	NULL
,	NULL
1991	NULL
6	NULL
.	NULL

Miyake	NULL
K	NULL
,	NULL
Medina	NULL
K	NULL
,	NULL
Hayashi	NULL
S-I	NULL
,	NULL
Ono	NULL
S	NULL
,	NULL
Hamaoka	NULL
T	NULL
,	NULL
Kincade	NULL
PW	NULL
:	NULL
Monoclonal	NULL
antibodies	NULL
to	NULL
Pgp-1/CD44	NULL
block	NULL
lympho-hemopoiesis	NULL
in	NULL
long-term	NULL
bone	NULL
marrow	NULL
cultures	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
171:477	NULL
,	NULL
1990	NULL
7	NULL
.	NULL

Oritani	NULL
K	NULL
,	NULL
Wu	NULL
X	NULL
,	NULL
Medina	NULL
K	NULL
,	NULL
Hudson	NULL
J	NULL
,	NULL
Miyake	NULL
K	NULL
,	NULL
Gimble	NULL
JM	NULL
,	NULL
Burstein	NULL
SA	NULL
,	NULL
Kincade	NULL
PW	NULL
:	NULL
Antibody	NULL
ligation	NULL
of	NULL
CD9	NULL
modifies	NULL
production	NULL
of	NULL
myeloid	NULL
cells	NULL
in	NULL
long-term	NULL
cultures	NULL
.	NULL

Blood	NULL
87:2252	NULL
,	NULL
1996	NULL
8	NULL
.	NULL

Piectrangeli	NULL
CE	NULL
,	NULL
Hayashi	NULL
S-I	NULL
,	NULL
Kincade	NULL
PW	NULL
:	NULL
Stromal	NULL
cell	NULL
lines	NULL
which	NULL
support	NULL
lymphocyte	NULL
growth	NULL
:	NULL
Characterization	NULL
,	NULL
sensitivity	NULL
to	NULL
radiation	NULL
and	NULL
responsiveness	NULL
to	NULL
growth	NULL
factors	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
18:863	NULL
,	NULL
1988	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MACROPHAGE	NULL
DIFFERENTIATION	NULL
AND	NULL
APOPTOSIS	NULL
9	NULL
.	NULL

Kincade	NULL
PW	NULL
,	NULL
Medina	NULL
K	NULL
,	NULL
Pictrangeli	NULL
CE	NULL
,	NULL
Hayashi	NULL
S-L	NULL
,	NULL
Naemen	NULL
AE	NULL
:	NULL
Stromal	NULL
cell	NULL
lines	NULL
which	NULL
support	NULL
lymphocyte	NULL
growth	NULL
II	NULL
.	NULL

Characteristics	NULL
of	NULL
a	NULL
suppressive	NULL
subclone	NULL
.	NULL

Adv	NULL
Exp	NULL
Med	NULL
Biol	NULL
292	NULL
:	NULL
227	NULL
,	NULL
1991	NULL
10	NULL
.	NULL

Van	NULL
Snick	NULL
J	NULL
:	NULL
Interleukin-6	NULL
:	NULL
An	NULL
overview	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
8:253	NULL
,	NULL
1990	NULL
11	NULL
.	NULL

Hirano	NULL
T	NULL
:	NULL
The	NULL
biology	NULL
of	NULL
interleukin-6	NULL
.	NULL

Chem	NULL
Immunol	NULL
51:153	NULL
,	NULL
1992	NULL
12	NULL
.	NULL

Hirano	NULL
T	NULL
:	NULL
Interleukin	NULL
6	NULL
and	NULL
its	NULL
receptor	NULL
:	NULL
Ten	NULL
years	NULL
later	NULL
.	NULL

Int	NULL
Rev	NULL
Immunol	NULL
16:249	NULL
,	NULL
1998	NULL
13	NULL
.	NULL

Muraguchi	NULL
A	NULL
,	NULL
Hirano	NULL
T	NULL
,	NULL
Tang	NULL
B	NULL
,	NULL
Matsuda	NULL
T	NULL
,	NULL
Horii	NULL
Y	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Kishimoto	NULL
T	NULL
:	NULL
The	NULL
essential	NULL
role	NULL
of	NULL
B	NULL
cell	NULL
stimulatory	NULL
factor-2	NULL
(	NULL
BSE-2/IL-6	NULL
)	NULL
for	NULL
the	NULL
terminal	NULL
differentiation	NULL
of	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
167:332	NULL
,	NULL
1988	NULL
14	NULL
.	NULL

Kawano	NULL
M	NULL
,	NULL
Hirano	NULL
T	NULL
,	NULL
Matsuda	NULL
T	NULL
,	NULL
Taga	NULL
T	NULL
,	NULL
Horii	NULL
Y	NULL
,	NULL
Iwato	NULL
K	NULL
,	NULL
Asaoku	NULL
H	NULL
,	NULL
Tang	NULL
B	NULL
,	NULL
Tanabe	NULL
O	NULL
,	NULL
Tanaka	NULL
H	NULL
,	NULL
Kuramoto	NULL
K	NULL
,	NULL
Okada	NULL
N	NULL
,	NULL
Kishimoto	NULL
T	NULL
:	NULL
Autocrine	NULL
generation	NULL
and	NULL
essential	NULL
requirement	NULL
of	NULL
BSF-2/	NULL
IL-6	NULL
for	NULL
human	NULL
multiple	NULL
myelomas	NULL
.	NULL

Nature	NULL
332:83	NULL
,	NULL
1988	NULL
15	NULL
.	NULL

Gauldie	NULL
J	NULL
,	NULL
Richards	NULL
C	NULL
,	NULL
Harnish	NULL
D	NULL
,	NULL
Lansdrop	NULL
P	NULL
,	NULL
Baumann	NULL
H	NULL
:	NULL
Interferon	NULL
B2/B-cell	NULL
stimulatory	NULL
factor	NULL
type	NULL
2	NULL
shares	NULL
identity	NULL
with	NULL
monocyte-derived	NULL
hepatocyte-stimulating	NULL
factor	NULL
and	NULL
regulates	NULL
the	NULL
major	NULL
acute	NULL
phase	NULL
protein	NULL
response	NULL
in	NULL
liver	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
84:7251	NULL
,	NULL
1987	NULL
16	NULL
.	NULL

Miyaura	NULL
C	NULL
,	NULL
Onozaki	NULL
K	NULL
,	NULL
Akiyama	NULL
Y	NULL
,	NULL
Taniyama	NULL
T	NULL
,	NULL
Hirano	NULL
T	NULL
,	NULL
Kishimoto	NULL
T	NULL
,	NULL
Suda	NULL
T	NULL
:	NULL
Recombinant	NULL
human	NULL
interleukin	NULL
6	NULL
(	NULL
B	NULL
cell	NULL
stimulatory	NULL
factor	NULL
2	NULL
)	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
differentiation	NULL
of	NULL
mouse	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
(	NULL
M1	NULL
)	NULL
.	NULL

FEBS	NULL
Lett	NULL
234:17	NULL
,	NULL
1988	NULL
17	NULL
.	NULL

Oritani	NULL
K	NULL
,	NULL
Kaisho	NULL
T	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Retinoic	NULL
acid	NULL
inhibits	NULL
interleukin	NULL
6-induced	NULL
macrophage	NULL
differentiation	NULL
and	NULL
apoptosis	NULL
in	NULL
a	NULL
murine	NULL
hematopoietic	NULL
cell	NULL
line	NULL
,	NULL
Y6	NULL
.	NULL

Blood	NULL
80:2298	NULL
,	NULL
1992	NULL
18	NULL
.	NULL

Hibi	NULL
M	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
IL-6	NULL
cytokine	NULL
family	NULL
and	NULL
signal	NULL
transduction	NULL
:	NULL
A	NULL
model	NULL
of	NULL
the	NULL
cytokine	NULL
system	NULL
.	NULL

J	NULL
Mol	NULL
Med	NULL
74:1	NULL
,	NULL
1996	NULL
19	NULL
.	NULL

Thie	NULL
JN	NULL
:	NULL
STATs	NULL
:	NULL
Signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcrip-tion	NULL
.	NULL

Cell	NULL
84:331	NULL
,	NULL
1996	NULL
20	NULL
.	NULL

Yamanaka	NULL
Y	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Fukada	NULL
T	NULL
,	NULL
Hibi	NULL
M	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Differentiation	NULL
and	NULL
growth	NULL
arrest	NULL
signals	NULL
are	NULL
generated	NULL
through	NULL
the	NULL
cytoplasmic	NULL
resion	NULL
of	NULL
gp130	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
Stat3	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
15:1557	NULL
,	NULL
1996	NULL
21	NULL
.	NULL

Nakajima	NULL
K	NULL
,	NULL
Yamanaka	NULL
Y	NULL
,	NULL
Nakae	NULL
K	NULL
,	NULL
Kojima	NULL
H	NULL
,	NULL
Ichiba	NULL
M	NULL
,	NULL
Kiuchi	NULL
N	NULL
,	NULL
Kitaoka	NULL
T	NULL
,	NULL
Fukuda	NULL
T	NULL
,	NULL
Hibi	NULL
M	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
A	NULL
central	NULL
role	NULL
for	NULL
Stat3	NULL
in	NULL
IL-6-induced	NULL
regulation	NULL
of	NULL
growth	NULL
and	NULL
differentiation	NULL
in	NULL
M1	NULL
leukemia	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
15:3651	NULL
,	NULL
1996	NULL
22	NULL
.	NULL

Minami	NULL
M	NULL
,	NULL
Inoue	NULL
M	NULL
,	NULL
Wei	NULL
S	NULL
,	NULL
Takeda	NULL
K	NULL
,	NULL
Matsumoto	NULL
M	NULL
,	NULL
Kishimoto	NULL
T	NULL
,	NULL
Akira	NULL
S	NULL
:	NULL
STAT3	NULL
activation	NULL
is	NULL
a	NULL
critical	NULL
step	NULL
in	NULL
gp130-mediated	NULL
terminal	NULL
differentiation	NULL
and	NULL
growth	NULL
arrest	NULL
of	NULL
a	NULL
myeloid	NULL
cell	NULL
line	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:3963	NULL
,	NULL
1996	NULL
23	NULL
.	NULL

Ishihara	NULL
K	NULL
,	NULL
Medina	NULL
K	NULL
,	NULL
Hayashi	NULL
S	NULL
,	NULL
Pictrangeli	NULL
C	NULL
,	NULL
Namen	NULL
AE	NULL
,	NULL
Miyake	NULL
K	NULL
,	NULL
Kincade	NULL
PW	NULL
:	NULL
Stromal-cell	NULL
and	NULL
cytokine-dependent	NULL
lymphocyte	NULL
clones	NULL
which	NULL
span	NULL
the	NULL
pre-B-	NULL
to	NULL
B-cell	NULL
transition	NULL
.	NULL

Dev	NULL
Immunol	NULL
1:149	NULL
,	NULL
1991	NULL
24	NULL
.	NULL

Nakajima	NULL
K	NULL
,	NULL
Kusafuka	NULL
T	NULL
,	NULL
Takeda	NULL
T	NULL
,	NULL
Fujitani	NULL
Y	NULL
,	NULL
Nakae	NULL
K	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
novel	NULL
interleukin-6	NULL
response	NULL
element	NULL
containing	NULL
an	NULL
ETS-binding	NULL
site	NULL
and	NULL
a	NULL
CRE-like	NULL
site	NULL
in	NULL
the	NULL
JunB	NULL
promoter	NULL
.	NULL

Mol	NULL
Cel	NULL
Biol	NULL
13:3027	NULL
,	NULL
1993	NULL
25	NULL
.	NULL

Tsujimura	NULL
T	NULL
,	NULL
Hashimoto	NULL
K	NULL
,	NULL
Morii	NULL
E	NULL
,	NULL
Tunio	NULL
GM	NULL
,	NULL
Tsujino	NULL
K	NULL
,	NULL
Kondo	NULL
T	NULL
,	NULL
Kanakura	NULL
Y	NULL
,	NULL
Kitamura	NULL
Y	NULL
:	NULL
Involvement	NULL
of	NULL
transcription	NULL
factor	NULL
encoded	NULL
by	NULL
the	NULL
mouse	NULL
mi	NULL
locus	NULL
(	NULL
MITF	NULL
)	NULL
in	NULL
apoptosis	NULL
of	NULL
cultured	NULL
mast	NULL
cells	NULL
induced	NULL
by	NULL
removal	NULL
of	NULL
interleukin-3	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
151:1043	NULL
,	NULL
1997	NULL
26	NULL
.	NULL

Davidson	NULL
WF	NULL
,	NULL
Pierce	NULL
JH	NULL
,	NULL
Rudikoff	NULL
S	NULL
,	NULL
Morse	NULL
HC	NULL
:	NULL
Relationship	NULL
between	NULL
B	NULL
cell	NULL
and	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Studies	NULL
with	NULL
a	NULL
B	NULL
lymphocyte	NULL
progenitor	NULL
line	NULL
,	NULL
HAFTL-1	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
168:389	NULL
,	NULL
1988	NULL
27	NULL
.	NULL

Hara	NULL
H	NULL
,	NULL
Sam	NULL
M	NULL
,	NULL
Maki	NULL
RA	NULL
,	NULL
Wu	NULL
GE	NULL
,	NULL
Paige	NULL
CJ	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
70Z/3	NULL
pre-B	NULL
cell	NULL
derived	NULL
macrophage	NULL
clone	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
Hox	NULL
family	NULL
gene	NULL
.	NULL

Int	NULL
Immunol	NULL
2:691	NULL
,	NULL
1990	NULL
28	NULL
.	NULL

Tanaka	NULL
T	NULL
,	NULL
Wu	NULL
GEB	NULL
,	NULL
Paige	NULL
CJ	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
1353	NULL
macrophage	NULL
lineage	NULL
transition	NULL
in	NULL
70Z/3	NULL
cells	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
24:1544	NULL
,	NULL
1994	NULL
29	NULL
.	NULL

Bretz	NULL
JD	NULL
,	NULL
Chen	NULL
SC	NULL
,	NULL
Redenius	NULL
D	NULL
,	NULL
Chang	NULL
HL	NULL
,	NULL
Esselman	NULL
WJ	NULL
,	NULL
Schwartz	NULL
RC	NULL
:	NULL
Lineage	NULL
switch	NULL
macrophages	NULL
can	NULL
present	NULL
antigen	NULL
.	NULL

Dev	NULL
Immunol	NULL
2:249	NULL
,	NULL
1992	NULL
30	NULL
.	NULL

Spencker	NULL
T	NULL
,	NULL
Neumann	NULL
D	NULL
,	NULL
Strasser	NULL
A	NULL
,	NULL
Resch	NULL
K	NULL
,	NULL
Martin	NULL
M	NULL
:	NULL
Lineage	NULL
switch	NULL
of	NULL
a	NULL
mouse	NULL
pre-B	NULL
cell	NULL
line	NULL
(	NULL
SPGM-1	NULL
)	NULL
to	NULL
macrophage-like	NULL
cells	NULL
after	NULL
incubation	NULL
with	NULL
phorbol	NULL
ester	NULL
and	NULL
calcium	NULL
ionophore	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
216:540	NULL
,	NULL
1995	NULL
31	NULL
.	NULL

Klinken	NULL
SP	NULL
,	NULL
Alexander	NULL
WS	NULL
,	NULL
Adams	NULL
JM	NULL
:	NULL
Hemopoictic	NULL
lincage	NULL
switch	NULL
:	NULL
v-raf	NULL
oncogene	NULL
converts	NULL
Emu-myc	NULL
transgenic	NULL
B	NULL
cells	NULL
into	NULL
macrophages	NULL
.	NULL

Cell	NULL
53:857	NULL
,	NULL
1988	NULL
32	NULL
.	NULL

Borzillo	NULL
GV	NULL
,	NULL
Ashmun	NULL
RA	NULL
,	NULL
Sherr	NULL
CJ	NULL
:	NULL
;	NULL
Macrophage	NULL
lineage	NULL
switching	NULL
of	NULL
murine	NULL
early	NULL
pre-B	NULL
lymphoid	NULL
cells	NULL
expressing	NULL
transduced	NULL
fms	NULL
genes	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:2703	NULL
,	NULL
1990	NULL
33	NULL
.	NULL

Darnell	NULL
JJ	NULL
,	NULL
Kerr	NULL
IM	NULL
,	NULL
Stark	NULL
GR	NULL
:	NULL
Jak-STAT	NULL
pathways	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
and	NULL
other	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
.	NULL

Science	NULL
264:1415	NULL
,	NULL
1994	NULL
34	NULL
.	NULL

Meraz	NULL
MA	NULL
,	NULL
White	NULL
JM	NULL
,	NULL
Sheedhan	NULL
KCF	NULL
,	NULL
Bach	NULL
EA	NULL
,	NULL
Rodig	NULL
SJ	NULL
,	NULL
Dighe	NULL
AS	NULL
,	NULL
Kaplan	NULL
DH	NULL
,	NULL
Riley	NULL
JK	NULL
,	NULL
Gleenlund	NULL
AC	NULL
,	NULL
Campbell	NULL
D	NULL
,	NULL
Carver-Moore	NULL
K	NULL
,	NULL
DuBois	NULL
RN	NULL
,	NULL
Clark	NULL
R	NULL
,	NULL
Aguet	NULL
M	NULL
,	NULL
Schreiber	NULL
RD	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
mouse	NULL
Stat1	NULL
gene	NULL
in	NULL
mice	NULL
reveals	NULL
unexpected	NULL
physiologic	NULL
specificity	NULL
in	NULL
the	NULL
JAK-STAT	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
84:431	NULL
,	NULL
1996	NULL
35	NULL
.	NULL

Durbin	NULL
JE	NULL
,	NULL
Hachenmiller	NULL
R	NULL
,	NULL
Simon	NULL
MC	NULL
,	NULL
Levy	NULL
DE	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
mouse	NULL
Statl	NULL
gene	NULL
results	NULL
in	NULL
compromised	NULL
innate	NULL
immunity	NULL
to	NULL
viral	NULL
disease	NULL
.	NULL

Cell	NULL
84:443	NULL
,	NULL
1996	NULL
36	NULL
.	NULL

Kaplan	NULL
MH	NULL
,	NULL
Sun	NULL
YL	NULL
,	NULL
Hoey	NULL
T	NULL
,	NULL
Grusby	NULL
MJ	NULL
:	NULL
Impaired	NULL
IL12	NULL
responses	NULL
and	NULL
enhanced	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
in	NULL
Stat4-deficient	NULL
mice	NULL
.	NULL

Nature	NULL
382:174	NULL
,	NULL
1996	NULL
37	NULL
.	NULL

Thierfelder	NULL
WE	NULL
,	NULL
van	NULL
Deursen	NULL
JM	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Tripp	NULL
RA	NULL
,	NULL
Sarawar	NULL
SR	NULL
,	NULL
Carson	NULL
RT	NULL
,	NULL
Sangster	NULL
MY	NULL
,	NULL
Vignali	NULL
DAA	NULL
,	NULL
Doherty	NULL
PC	NULL
,	NULL
Grosveld	NULL
GC	NULL
,	NULL
Thile	NULL
JN	NULL
:	NULL
Requirement	NULL
for	NULL
Stat4	NULL
in	NULL
interleukin-12-mediated	NULL
responses	NULL
of	NULL
natural	NULL
killer	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
382:171	NULL
,	NULL
1996	NULL
38	NULL
.	NULL

Shimoda	NULL
K	NULL
,	NULL
van	NULL
Deusen	NULL
JM	NULL
,	NULL
Sangster	NULL
MY	NULL
,	NULL
Sarwar	NULL
SR	NULL
,	NULL
Carson	NULL
RT	NULL
,	NULL
Tripp	NULL
RA	NULL
,	NULL
Chu	NULL
C	NULL
,	NULL
Qualle	NULL
FW	NULL
,	NULL
Nosaka	NULL
T	NULL
,	NULL
Vignali	NULL
S	NULL
,	NULL
Doherty	NULL
PC	NULL
,	NULL
Grosveld	NULL
G	NULL
,	NULL
Paul	NULL
W	NULL
,	NULL
Thle	NULL
JN	NULL
:	NULL
Lack	NULL
of	NULL
IL-4-induced	NULL
Th2	NULL
response	NULL
and	NULL
IgE	NULL
class	NULL
switching	NULL
in	NULL
mice	NULL
with	NULL
disrupted	NULL
Stat6	NULL
gene	NULL
.	NULL

Nature	NULL
380:630	NULL
,	NULL
1996	NULL
39	NULL
.	NULL

Takeda	NULL
K	NULL
,	NULL
Tanaka	NULL
T	NULL
,	NULL
Shi	NULL
W	NULL
,	NULL
Matsumoto	NULL
M	NULL
,	NULL
Minami	NULL
M	NULL
,	NULL
Kashiwamura	NULL
S	NULL
,	NULL
Nakanishi	NULL
K	NULL
,	NULL
Yoshida	NULL
N	NULL
,	NULL
Kishimoto	NULL
T	NULL
,	NULL
Akira	NULL
S	NULL
:	NULL
Essential	NULL
role	NULL
of	NULL
Stat6	NULL
in	NULL
IL-4	NULL
signaling	NULL
.	NULL

Nature	NULL
380:627	NULL
,	NULL
1996	NULL
40	NULL
.	NULL

Lutticken	NULL
C	NULL
,	NULL
Wegenka	NULL
UM	NULL
,	NULL
Yuan	NULL
J	NULL
,	NULL
Buschmann	NULL
J	NULL
,	NULL
Schindler	NULL
C	NULL
,	NULL
Ziemiecki	NULL
A	NULL
,	NULL
Harpar	NULL
AG	NULL
,	NULL
Wilks	NULL
AF	NULL
,	NULL
Yasukawa	NULL
K	NULL
,	NULL
Taga	NULL
T	NULL
,	NULL
Kishimoto	NULL
T	NULL
,	NULL
Barbieri	NULL
G	NULL
,	NULL
Pellegrini	NULL
S	NULL
,	NULL
Sendtner	NULL
M	NULL
,	NULL
Heinrich	NULL
PC	NULL
,	NULL
Horn	NULL
F	NULL
:	NULL
Association	NULL
of	NULL
transcription	NULL
factor	NULL
APRF	NULL
and	NULL
protein	NULL
kinase	NULL
Jak1	NULL
with	NULL
the	NULL
interleukin-6	NULL
signal	NULL
transducer	NULL
gp130	NULL
.	NULL

Science	NULL
263:89	NULL
,	NULL
1994	NULL
41	NULL
.	NULL

Stahl	NULL
N	NULL
,	NULL
Farrugella	NULL
TJ	NULL
,	NULL
Boulton	NULL
TG	NULL
,	NULL
Zhong	NULL
Z	NULL
,	NULL
Darnell	NULL
JE	NULL
,	NULL
Yancopoulas	NULL
G	NULL
:	NULL
Choice	NULL
of	NULL
STAT	NULL
's	NULL
and	NULL
other	NULL
substrates	NULL
specified	NULL
by	NULL
modular	NULL
tyrosine-based	NULL
motifs	NULL
in	NULL
cytokine	NULL
receptors	NULL
.	NULL

Science	NULL
267:1349	NULL
,	NULL
1995	NULL
42	NULL
.	NULL

Fujitani	NULL
Y	NULL
,	NULL
Nakajina	NULL
K	NULL
,	NULL
Kojima	NULL
H	NULL
,	NULL
Nakae	NULL
K	NULL
,	NULL
Takeda	NULL
T	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-6	NULL
response	NULL
element	NULL
in	NULL
the	NULL
jun	NULL
B	NULL
promoter	NULL
is	NULL
mediated	NULL
by	NULL
multiple	NULL
Stat	NULL
family	NULL
proteins	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
202:1181	NULL
,	NULL
1994	NULL
43	NULL
.	NULL

Ellis	NULL
RE	NULL
:	NULL
Mechanisms	NULL
and	NULL
functions	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Annu	NULL
Rev	NULL
Cell	NULL
Biol	NULL
7:663	NULL
,	NULL
1991	NULL
44	NULL
.	NULL

Green	NULL
DR	NULL
,	NULL
Bissonnette	NULL
RP	NULL
,	NULL
Glynn	NULL
JM	NULL
,	NULL
Shi	NULL
Y	NULL
:	NULL
Activation-induced	NULL
apoptosis	NULL
in	NULL
lymphoid	NULL
systems	NULL
.	NULL

Semin	NULL
Immunol	NULL
4:379	NULL
,	NULL
1992	NULL
45	NULL
.	NULL

Williams	NULL
GT	NULL
:	NULL
Programmed	NULL
cell	NULL
death	NULL
:	NULL
Apoptosis	NULL
and	NULL
oncogen-esis	NULL
.	NULL

Cell	NULL
65:1097	NULL
,	NULL
1991	NULL
46	NULL
.	NULL

Mangan	NULL
DF	NULL
,	NULL
Wahl	NULL
H	NULL
:	NULL
Differential	NULL
regulation	NULL
of	NULL
human	NULL
monocyte	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
apoptosis	NULL
)	NULL
by	NULL
chemotactic	NULL
factors	NULL
and	NULL
pro-inflammatory	NULL
cytokines	NULL
.	NULL

J	NULL
Immunol	NULL
147:3408	NULL
,	NULL
1991	NULL
47	NULL
.	NULL

Yang	NULL
E	NULL
,	NULL
Zha	NULL
J	NULL
,	NULL
Jockel	NULL
J	NULL
,	NULL
Boise	NULL
LH	NULL
,	NULL
Thompson	NULL
CB	NULL
,	NULL
Korsmeyer	NULL
SJ	NULL
:	NULL
Bad	NULL
,	NULL
a	NULL
heterodimeric	NULL
partner	NULL
for	NULL
Bcl-XL	NULL
and	NULL
Bcl-2	NULL
,	NULL
displaces	NULL
Bax	NULL
and	NULL
promotes	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
80:285	NULL
,	NULL
1995	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1354	NULL
48	NULL
.	NULL

Benito	NULL
A	NULL
,	NULL
Grillot	NULL
D	NULL
,	NULL
Nunez	NULL
G	NULL
,	NULL
Fernandez-Luna	NULL
JL	NULL
:	NULL
Regulation	NULL
and	NULL
function	NULL
of	NULL
Bcel-2	NULL
during	NULL
differentiation-induced	NULL
cell	NULL
death	NULL
in	NULL
HL-60	NULL
promyelocytic	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
146:481	NULL
,	NULL
1995	NULL
49	NULL
.	NULL

Sanz	NULL
C	NULL
,	NULL
Benito	NULL
A	NULL
,	NULL
Silva	NULL
M	NULL
,	NULL
Albella	NULL
B	NULL
,	NULL
Richard	NULL
C	NULL
,	NULL
Segovia	NULL
JC	NULL
,	NULL
Insunza	NULL
A	NULL
,	NULL
Bueren	NULL
JA	NULL
,	NULL
Fernandez-Luna	NULL
JL	NULL
:	NULL
The	NULL
expression	NULL
of	NULL
Bcl-x	NULL
is	NULL
downregulated	NULL
during	NULL
differentiation	NULL
of	NULL
human	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
along	NULL
the	NULL
granulocyte	NULL
but	NULL
not	NULL
the	NULL
monocyte/macrophage	NULL
lineage	NULL
.	NULL

Blood	NULL
89:3199	NULL
,	NULL
1997	NULL
50	NULL
.	NULL

Wilson	NULL
BE	NULL
,	NULL
Mochon	NULL
E	NULL
,	NULL
Boxer	NULL
LM	NULL
:	NULL
Induction	NULL
of	NULL
bel-2	NULL
expression	NULL
by	NULL
phosphorylated	NULL
CREB	NULL
proteins	NULL
during	NULL
B-cell	NULL
activation	NULL
and	NULL
rescue	NULL
from	NULL
apoptosis	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:5546	NULL
,	NULL
1996	NULL
51	NULL
.	NULL

Haldar	NULL
S	NULL
,	NULL
Negrini	NULL
M	NULL
,	NULL
Monne	NULL
M	NULL
,	NULL
Sabbioni	NULL
S	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
Down-regulation	NULL
of	NULL
bel-2	NULL
by	NULL
p53	NULL
in	NULL
breast	NULL
cancer	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
54:2095	NULL
,	NULL
1994	NULL
52	NULL
.	NULL

Salomoni	NULL
P	NULL
,	NULL
Perrotti	NULL
D	NULL
,	NULL
Martinez	NULL
R	NULL
,	NULL
Franceschi	NULL
C	NULL
,	NULL
Calabretta	NULL
B	NULL
:	NULL
Resistance	NULL
to	NULL
apoptosis	NULL
in	NULL
CTLL-2	NULL
cells	NULL
constitutively	NULL
expressing	NULL
c-Myb	NULL
is	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
BCL-2	NULL
expression	NULL
and	NULL
Myb-	NULL
ORITANI	NULL
ET	NULL
AL	NULL
dependent	NULL
regulation	NULL
of	NULL
bel-2	NULL
promoter	NULL
activity	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
94:3296	NULL
,	NULL
1997	NULL
53	NULL
.	NULL

Fukada	NULL
T	NULL
,	NULL
Hibi	NULL
M	NULL
,	NULL
Yamanaka	NULL
Y	NULL
,	NULL
Tezuka	NULL
M	NULL
,	NULL
Fujitani	NULL
Y	NULL
,	NULL
Yamagu-chi	NULL
T	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Two	NULL
signals	NULL
are	NULL
necessary	NULL
for	NULL
cell	NULL
proliferation	NULL
induced	NULL
by	NULL
a	NULL
cytokine	NULL
receptor	NULL
gp130	NULL
:	NULL
Involvement	NULL
of	NULL
STAT3	NULL
in	NULL
anti-apoptosis	NULL
.	NULL

Immunity	NULL
5:449	NULL
,	NULL
1996	NULL
54	NULL
.	NULL

Nakajima	NULL
K	NULL
,	NULL
Matsuda	NULL
T	NULL
,	NULL
Fujitani	NULL
Y	NULL
,	NULL
Kojima	NULL
H	NULL
,	NULL
Yamanaka	NULL
Y	NULL
,	NULL
Nakae	NULL
K	NULL
,	NULL
Takada	NULL
T	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Signal	NULL
transduction	NULL
through	NULL
IL-6	NULL
receptor	NULL
:	NULL
Involvement	NULL
of	NULL
multiple	NULL
protein	NULL
kinases	NULL
,	NULL
stat	NULL
factors	NULL
,	NULL
and	NULL
a	NULL
novel	NULL
H7-sensitive	NULL
pathway	NULL
.	NULL

Ann	NULL
NY	NULL
Acad	NULL
Sci	NULL
762:55	NULL
,	NULL
1995	NULL
55	NULL
.	NULL

Narimatsu	NULL
M	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Ichiba	NULL
M	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Association	NULL
of	NULL
Stat3-dependent	NULL
transcriptional	NULL
activation	NULL
of	NULL
p19NÂ®4	NULL
with	NULL
IL-6-induced	NULL
growth	NULL
arrest	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
238:764	NULL
,	NULL
1997	NULL
56	NULL
.	NULL

Ichiba	NULL
M	NULL
,	NULL
Nakajima	NULL
K	NULL
,	NULL
Yamanaka	NULL
Y	NULL
,	NULL
Kiuchi	NULL
N	NULL
,	NULL
Hirano	NULL
T	NULL
:	NULL
Autoregulation	NULL
of	NULL
the	NULL
Stat3	NULL
gene	NULL
through	NULL
cooperation	NULL
with	NULL
a	NULL
cAMP-responsive	NULL
element	NULL
binding	NULL
protein	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
273:6132	NULL
,	NULL
1998	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Â®	NULL
blO	NULL
0d	NULL
1999	NULL
93	NULL
:	NULL
1346-1354	NULL
Both	NULL
Stat3-Activation	NULL
and	NULL
Stat3-Independent	NULL
BCL2	NULL
Downregulation	NULL
Are	NULL
Important	NULL
for	NULL
Interleukin-6-Induced	NULL
Apoptosis	NULL
of	NULL
1A9-M	NULL
Cells	NULL
Kenji	NULL
Oritani	NULL
,	NULL
Yoshiaki	NULL
Tomiyama	NULL
,	NULL
Paul	NULL
W.	NULL
Kincade	NULL
,	NULL
Keisuke	NULL
Aoyama	NULL
,	NULL
Takafumi	NULL
Yokota	NULL
,	NULL
Itaru	NULL
Matsumura	NULL
,	NULL
Yuzuru	NULL
Kanakura	NULL
,	NULL
Koichi	NULL
Nakajima	NULL
,	NULL
Toshio	NULL
Hirano	NULL
and	NULL
Yuji	NULL
Matsuzawa	NULL
4	NULL
VIN	NULL
â	NULL
CA	NULL
VJ-	NULL
,	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

2	NULL
YOtowÂ®	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/93/4/1346.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Neoplasia	NULL
(	NULL
4182	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

